Present review article describing effects of garlic components on induction of apoptosis, cell cycle check points and inhibition of cancer cell proliferation. Garlic derived organic compounds hold unique therapeutic potential and induces apoptotic signaling pathways; do cell cycle arrest, and show cytotoxic and anti-invasive activity to a variety of cancer cells. Regular dietary intake of garlic cut down neoplastic growth, cancer cell proliferation, and induces programmed cell death. Garlic components act as tumor suppressor agents and prevent aberrant cell expansion by slowing down the cell cycle, or by inducing apoptosis. These apoptosis inducers can act on various apoptosis-related proteins to promote apoptotic cell death. Garlic based nanoformulations can target oncogenic mutations which disrupt apoptosis. These can inhibit cellular changes leading to tumor initiation, progression of metastasis. Garlic derivatives can control DNA damage thereby slow down oncogenic changes and induce caspase activity which halts or stalls mutation in p53 gene and thereby stops growth of lung, colon, and breast cancer. More often, new combinations of garlic components may stop cancer progression as well as multistage carcinogenesis. No doubt garlic components can be used in designing best possible molecular targets of cancer cells and that could be recommended for clinical management of different types of cancer.
Allium sativum, commonly known as lahsun in Hindi (Garlic in English) belongs to family Alliaceae and plant order liliales 1 Plant has been used for centuries as a nutraceutical, prophylactic and therapeutic medicinal agent. Garlic is a perennial, erect, bulbous herb indigenous to Asia but it is commercially grown in many parts of the world. It is a main singular and combined foodstuff which is used in Traditional Medicine of India. Allium sativum L. is an important aromatic plant and has multiple uses 2. It is a rich source of organo-sulfur compounds, which are thought to be responsible for its flavor and aroma, as well as its potential health benefits 3. It is also used for both culinary and medicinal purposes by many cultures for centuries 4. Garlic is a multi-component pioneer food contains good nutraceuticals which are highly protective to lung cancer and increase the life expectancy in cancer patients 4, 5, 6. Dietary consumption of green garlic bulbs reduce all types of cancer risks 7. It stops invasion and progression of cervical cancer 8. Homemade garlic ailments and preparations are used as herbal drug for complementary therapy of cancer. Garlic oil inhibits proliferation of AsPC-1, PANC-1, and Mia PaCa-2 cells while garlic tea shows strong therapeutic potential against lung and colorectal cancer 9. Both black and green garlic extracts (BGE) check proliferation of lung 10 and colorectal cancer and inhibits other types of carcinoma 11. It contains S-allylcysteine (SAC), one of the major water-soluble compounds significantly inhibit oncogenesis 12 while, S-Allylmercaptocysteine (CySSA) is known to exhibit anti-cancer effects 13. Alliin, isolated from garlic (Allium sativum) prevents LPS-induced inflammation in 3T3-L1 adipocytes. Similarly, DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition 14 (Table 1). Cyclic sulfoxides garlicnins B2, B3, B4, C2, and C3 isolated from Allium sativum are toxic to cancer cells 15. Conjugates of daidzein-alliinase are used as a targeted pro-drug enzyme system against ovarian carcinoma 16.
Both allicin and allyl-mixed disulfides with proteins and small thiol molecules show good anticancer activity 3 and are considered as safe botanicals 17 (Table 1). These compounds induce of apoptosis in tumor cells and show multiple therapeutic potential 18 against different types of cancers 19. Alliin, prevents LPS-induced inflammation in 3T3-L1 adipocytes) 20 while thiacremonone shows anticancer activity and does down regulation of peroxiredoxin 21. Black garlic extract is strong inhibitor of lung cancer cell proliferation and radio sensitization 10 (Table 1). Thiacremonone (2, 4-dihydroxy-2, 5-dimethyl-thiophene-3-one is sulfur compound from garlic 21 shows inhibition of NF-kappaB and cancer cell growth with IC(50) values about 100 microg/mL in colon cancer cells) 22. Garlic, silver bullets are used for carcinoma surveillance in upper endoscopy for Barrett's esophagus 23 (Table 1).
Induction of apoptosis depends on the redox-state of the cell, with anti-oxidants being able to prevent sulfide-induced apoptosis 24. Both growth arrest and induction of apoptosis is associated with a considerable reduction of the level of cdc25C and p53 gene mutations and its expression in cells. Garlic derived polysulfides induce apoptosis 24 and can control cancer cell proliferation, angiogenesis and metastasis at physiological dose. Garlic components may participate in regulation of cellular differentiation and cell death much similar to oncogenes and tumor suppressor genes or induce their activity that play an important role in this process by regulating either cellular proliferation. There is a possibility that garlic may restore all three different categories of cancer associated genes. First category of proto-oncogenes and their oncogenic counterparts encodes proteins that induce cellular proliferation. Some of these proteins function as growth factors or growth factor receptors in normal cells, and its expression is carefully regulated. Garlic possesses apoptosis inducers which act on several apoptosis-related proteins to promote apoptotic cell death. Even its components also bind to most of the growth factor receptors and normalize any type of aberration related to gene function. A second category of genes called tumor suppressor genes or anti-oncogenes encodes proteins that inhibit excessive cell proliferation. Inactivation of these genes results in unregulated proliferation. Garlic antioxidants and enzymatic inhibitors check unregulated cellular proliferation by making interference in metabolic pathways which synthesize cancer growth promoting factors.
A defective or inefficient apoptosis is a characteristic feature of cancer cells that needs induction but garlic derived polysulfides lead to induction of apoptosis 24. These may induce apoptosis through p53-dependent and independent pathways, which facilitate cytochrome c release from mitochondria. Hence, there should be more appropriate and authentic information is needed on target specificity of cancer agents which induce apoptosis. Though from biochemical researches cytotoxic potential of garlic components is established but target specificity explanation is still lacking. Therefore, all intriguing possibilities that are responsible for defects in apoptotic pathways which contribute to treatment failure can be resolved by making appropriate combinations of garlic components for cancer control. It also needs a thorough understanding about apoptotic signaling pathways to unravel novel drug targets and finding proper therapeutic solutions. Further, these should be compared for better cancer therapeutics with effect of certain oncogenes such as E1A and c-myc. Among all efficacies new induction of apoptotic signaling pathways in cancer cells be needed to resist apoptotic insults, with strong efforts to target the mitochondrion for restoring efficient cell death signaling in cancer cells. Hence, there is an immense need to make conceptual framework that can link cancer genetics with cancer therapy. Present review article describes use of garlic components for inducing apoptosis via small molecule drug treatments, its receptor ligation, and cytotoxic action. Further, nanoformulations which could target oncogenic mutations, disrupt apoptosis, reduce the chances of tumor initiation, progression and metastasis should prepare. These nanoformulations may induce apoptosis by making changes in mitochondrial membrane potential, phosphatidylserine membrane localization, DNA content, and antigen cleavage. Hence, best possible drug targets must explore to stop cancer progression and producing selective pressure to override apoptosis so then multistage carcinogenesis could be finished by opting new combinations of garlic components. Garlic based herbal products and targeted molecules can be recommended for clinical management of various cancer types.
CASP3 protein is an important member of the cysteine-aspartic acid protease (caspase) family 25. Caspases exist as inactive proenzymes in the cells which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 6 and 7; and the protein itself is processed and activated by caspases 8, 9, and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. After alternative splicing this gene results in two transcript variants that encode the same protein 26 Caspase-3 is activated in the apoptotic cell both by extrinsic (death ligand) and intrinsic (mitochondrial) pathways 27. Garlic induces caspase activity which halts or stalls mutation in p53 gene and thereby stops growth of lung, colon, and breast cancer. It supports non-apoptotic roles of many effectors to the apoptotic signaling pathways. Similarly, diallyl trisulfide-induce apoptosis of bladder cancer cells which is caspase-dependent and regulated by PI3K/Akt and JNK pathways 28. DADS also induce phosphatidylserine translocation from the inner to the outer leaflet of the plasma membrane and activate caspase-3 activity. Like caspase 3, caspase 2, plays important role in cell cycle regulation, DNA repair, and tumor suppression 29. Garlic components act upon two pathways of target cell apopotosis stimulated by CTLs and through Fas pathway in which ligation of trimeric Fas units by CTL borne Fas ligands leads to the association of death domains of Fas with FADD. These components regulate a series of reactions that could lead to apoptosis of target cell. Garlic components may induce CTL functions and activating caspase cascade that results in the apoptotic death of the cell death by invoking mitochondrially mediated death pathways.
Normally in healthy cell three important genes reside i.e. proto-oncogenes, oncogenes, and a third category of cancer associated genes which regulate programmed cell death. These genes encode proteins that either block or induce apoptosis; bcl-2 is an anti-apoptosis gene. DATS-induce apoptosis and does down-regulation of Bcl-2, Akt and cyclin D1 protein levels, and up-regulation of Bax, Fas, p53 and cyclin B protein levels in Capan-2 cells 30 (Table 1). More specifically carcinogens and viruses might alter the regulated function of these genes and converting them into potent cancer causing genes. In such condition garlic derived components mainly sulfur compounds, saponins and vitamins can evoke tumor suppressor gene and stop conversion of proto-oncogenes in to oncogenes. All this is possible due to genetic rearrangements of proto-oncogenes and mutations. Obviously, conversion of proto-oncogenes into oncogenes involves mutation that may result in production of qualitatively different gene products that may harm normal physiological metabolism of a normal cell. Further, viral integration into the host genome serves to convert a proto-oncogene into a transforming oncogene. Retroviruses have shown to integrate within the c-myc proto-oncogene. Such transformed or metastatic cells can be depleted by programmed cell death only thorough apoptosis induction pathways. That is possible by garlic component dosage as DADS modulates the cellular levels of Bax, Bcl-2, Bcl-xL, and Bcl-w in a dose-dependent manner, and induce apoptosis in the MCF-7 breast-cancer cell line through interfering with cell-cycle growth phases in a way that increases the sub-G(0) population and substantially halts DNA synthesis 28.
2.2. Induction of Apoptosis-related ProteinsApoptosis is followed by two types of death pathways, namely, the extrinsic pathway and the mitochondria-mediated pathway. Both are linked and molecules used in one pathway can influence the other 31. Apoptosis imparts cell shrinkage, blebbing of plasma membrane, affect maintenance of organelle integrity, condensation and fragmentation of DNA, followed by ordered removal of phagocytes 32. Apoptosis is a suicidal self managed operation that kills cancer cells and maintain minimal damage to surrounding tissues. Apoptosis is regulated by the Bcl-2 family of proteins i.e. Bcl-2, Bcl-XL, and Mcl-1 which are anti-apoptotic proteins that possess all the four domains (BH1-4). These proteins regulate apoptotic events and share homology in any of the four common Bcl-2 homology (BH) domains 33. The second category of Bcl-2 family of proteins contains BH domains 1, 2 and 3. These proteins would include Bax, Ki-67 and Bak. Bax is a pro-apoptotic protein that resides in the cytosol under physiological conditions. The third group of Bcl-2 family of proteins is the BH3-only proteins. The BH3-only family members include Bim, Bad, Bmf, Noxa and Puma. They act by neutralizing the anti-apoptotic proteins 33. Apoptosis is induced in experimental systems through a variety of methods but two known methods i.e. biological induction and chemical induction are well used. In biological induction activation of Fas or TNF receptors by their respective ligands, or by cross-linking with an agonist antibody, induces apoptosis of Fas- or TNF receptor-bearing cells. In chemical apoptosis inducers act on several apoptosis-related proteins to promote apoptotic cell death 30.
Few important derivatives from garlic such as allicin, ajoene, DAS, DADS, DATS, and SAMC, have been found to induce apoptosis and cell cycle arrest in various cancer cell lines grown in culture. There are many more possibilities that different natural products may choose different pathway to maintain apoptosis in cancer cells. Garlic oil induce programmed cell death, cell cycle arrest, and show pro-apoptosis effects in AsPC-1 cells 34 and human pancreatic carcinoma cells 34. Depending on the agent selected and the concentrations used, apoptotic events can be detected between 8–72 h post-treatment. S-allylcysteine is a potential therapeutic compound isolated from garlic derivative that suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro 35. S-allylcysteine is also used to enhance apoptosis in oral cancer (Table 1) and human breast cancer cells through ROS-mediated activation of JNK and AP-1 36. Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway 37. It induces p53-mediated autophagy in Hep G2 human liver cancer cells 4, 38 and induces apoptosis in EL-4 cells in vitro by activation of expression of caspase-3 and -12 and up-regulation of the ratio of Bax/Bcl-2 39. It also induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways 40. Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2 41. while diallylpolysulfides induce growth arrest and apoptosis in cancer cells (Busch et al., 2010) 24. Allicin induce autophagic cell death in human HCC Hep G2 (p53(wild type) cells, it may also induce apoptotic cell death through caspase-dependent and caspase-independent pathways by overproduction of reactive oxygen species (ROS) in human HCC Hep 3B (p53(mutation)) cells. Moreover, in cell death mechanism p53 knocked down Hep G2, and silenced the p53 gene using siRNA-mediated silencing. However, allicin treatment induces apoptotic cell death in p53 knocked down Hep G2 cells similar to that of Hep 3B cells 4. Allyl sulfides inhibit cell growth of skin cancer cells through induction of DNA damage mediated G2/M arrest and apoptosis 39.
In normal cells growth occurs at regular interval through well controlled phases of mitotic cell division. Apoptosis is highly important event because it controls cell number and support healthy cells to live and operate to kill old cells or defective cells. Diallyl tetrasulfide induce mitotic arrest to apoptosis 42. It also induces apoptosis in human primary colorectal cancer cells) 43 and AGS gastric cancer cell line 44. Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis) 45. It induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo 46. Similarly, di-allyl disulfide plays important role of in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines 47. Allyl sulfides inhibit cell growth of skin cancer cells through induction of DNA damage mediated G2/M arrest and apoptosis) 38 (Wang et al., 2010). Similarly, diallyl trisulfide 30 and S-alkenylmercaptocysteine (CySSR) with sodium selenite induce apoptosis in pancreatic cells 13. DATS-induced apoptosis is related with induction of pro-apoptotic Bax protein and p53 protein expression that was found upregulated and translocation to nucleus in MCF-7 cells 48. DATS inhibits phosphatidylinositol 3'-kinase/Akt activation that, in turn, results in modulation of Bcl-2 family proteins, leading to enhanced apoptosis of T24 cells) 39. This is the possible mechanism by which allyl sulfides suppress neoplastic cell proliferation 49. S-benzyl-cysteine mediate cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells 50 (Table 1). Thiacremonone inhibits lung cancer cell growth in a concentration dependent manner through induction of apoptotic cell death accompanied by induction of cleaved caspase-3, -8, -9, Bax, p21 and p53, but decrease of xIAP, cIAP and Bcl2 expression and inhibition of glutathione peroxidase activity of of PRDX6 through interaction ) 21.
2.3. Histone Deacetylation InhibitionHistone deacetylase inhibitors (HDIs) interfere with the function of histone deacetylase and are as possible treatments for cancers 51, 52. Sulfur compounds from garlic showed modulation of acetylation 53. These are cytostatic agents that inhibit the proliferation of tumor cells in culture in vitro while in vivo induce cell cycle arrest, cell differentiation and/or apoptosis. Histone deacetylase inhibitors exert their anti-tumor effects via the induction of expression changes of oncogenes or tumour suppressor genes, through modulating the acetylation/deactylation of histones and/or non-histone proteins such as transcription factors 55. Histone deacetylation inhibitors (HDACi) also suppress cancer growth and induce apoptosis in cancer cells. Similarly, DADS shows similar properties as HDACi in MCF-7 cells as it lowers the removal of an acetyl group from an acetylated substrate and induces histone-4 (H4) hyper-acetylation that may be responsible for the induction of apoptosis in breast cancer cells 56. In addition, di-allyl disulfide causes inhibition of histone deacetylation may also an important check point 56. Histone deacetylase inhibition induces the accumulation of hyperacetylated nucleosome core histones in most regions of chromatin but affects the expression of only a small subset of genes, leading to transcriptional activation of some genes, but repression of an equal or larger number of other genes. Garlic compounds inhibit histone deacetylase activity and induce histone hyperacetylation in vitro as well as in vivo 56. Thus both histone acetylation and deacetylation play important roles in the modulation of chromatin topology and the regulation of gene transcription 56 and are responsible for the induction of apoptosis in breast cancer cells 56. DADS is able to increase PGC1α expression in a ROS-dependent manner and to induce mitochondrial biogenesis at early stage of treatment that precede cell cycle arrest and apoptosis outcome 57. DADS also elicits the increase of PGC1α within nuclear compartment, the decrease of PGC1α non-active acetylated form and does induction of nuclear-encoded mitochondrial genes such as TFAM and TFBM1) 57. There are clear evidences about involvement of histone acetylation in modulation of gene expression by diallyl disulfide and allyl mercaptan 57.
2.4. Cell Cycle Checks PointsCell cycle checkpoints are control mechanisms in eukaryotic cells which ensure proper division of the cell. Each checkpoint serves as a potential halting point along the cell cycle, during which the conditions of the cell are assessed, with progression through the various phases of the cell cycle occurring when favorable conditions are met. There are three known checkpoints: the G1 checkpoint, also known as the restriction or start checkpoint; the G2/M checkpoint; and the metaphase checkpoint, also known as the spindle checkpoint. The cell cycle checkpoints play an important role in the control system by sensing defects that occur during essential processes such as DNA replication or chromosome segregation, and inducing a cell cycle arrest in response until the defects are repaired 58. Cell cycle in eukaryotes is a complex process, which is maintained by a network of regulatory proteins, or cell cycle control system. This system monitors and dictates the progression of the cell through the cell cycle 59. Cell cycle checkpoints are maintained through the regulation of the activities of a family of protein kinases known as the cyclin-dependent kinases (CDKs), which bind to different classes of regulator proteins known as cyclins, with specific cyclin-CDK complexes being formed and activated at different phases of the cell cycle. Those complexes, in turn, activate different downstream targets to promote or prevent cell cycle progression 60.
In normal cells, the cell cycle is tightly regulated to ensure faithful DNA replication and chromosomal segregation prior to cell division. Following DNA damage, the cell cycle can be transiently arrested to allow for DNA repair or activation of pathways leading to cell death (apoptosis). But in normal cells DNA damage is self repaired and cell tries to maintain cell cycle normal. There are certain cell cycle check points such as late G2 check point controls progression of cell cycle from G2 to M phase. Here, active Cdk1 (cdc2) for formation of complex, cyclin B1 is required. In next step for regulation of the cdc-B1 complex inhibitory phosphatases are needed at a pair of amino acids in the roofs of the active site by Wee1 (Figure 1 and Figure 2). After dephosporylation of these sites by the phosphatase Cdc25C increases Cdk activity. At this stage DNA damage activates Chk1 which inactivates Cdc25C through phosphorylation of cdc25C. This results in the phosphorylation and activity of cdc2-B1 and G2-M arrest (Figure 1 and Figure 2). Thus, G1/S is an important checkpoint that controls progression of cells through the restriction point (R) into the DNA synthesis S-phase (Figure 1 & Figure 2). During G1 stage, the tumor suppressor Rb binds and inhibits transcription factor E2F. More specifically, diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1 61, 47 while synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells 62 (Table 1). DAS also induce G0/G1 cell cycle arrest 63 and apoptosis in HeLa cells through caspase- and mitochondria and p53 pathways. It significantly inhibits the growth and induces apoptosis of human cervical cancer HeLa cells in vitro 64. DAS-induced G0/G1 phase arrest is mediated through the increased expression of p21, p27, and p53 with a simultaneous decrease in CDK2, CDK6, and CHK2 expression. DAS exposed Ca Ski cells undergo apoptosis, with significant morphological changes and DNA condensation. It leads to alter the ratio of Bax/Bcl-2, and induce mitochondrial dysfunction, that results in release of cytochrome c for causing apoptosis in Ca Ski cells. Due to these properties DAS is considered as potential chemotherapeutic agent for the treatment of cervical cancer 65. S-Allylmercaptocysteine does cell cycle arrest at the G2/M and sub-G1 interphases 13.
Diallyl disulphide, also found in Garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29)) 56. Garlic sulfur components may activate phosphorylation of Rb by cyclin-bound cyclin dependent kinases (CDK) in late G1 and induce dissociation of Rb protein and permits E2F-mediated transcription of S-phase-promoting genes 66. INK4 and Kip/Cip family inhibitors control CDK activity and prevent entry into S-phase after. DNA damage activates response pathways through ATM/ ATR and Chk1/2 kinases to block CDK activity 67, leading to cell cycle arrest and DNA repair or cell death 58 (Figure 1 and Figure 2). DATS suppress the viability of cultured human pancreatic cancer cells (Capan-2) and it increases the proportion of cells in the G2/M phase and induced apoptotic cell death. DATS enhance the expression of Fas, p21, p53 and cyclin B1, but down regulate the expression of Akt, cyclin D1, MDM2 and Bcl-2) 30. DATS induces cell cycle inhibition and elevated levels of cyclin B1 and p21, and reduced levels of cyclin D1 in Capan-2 cells and H6C7 cells) 30. DATS reduce mitosis in tumors, decrease HDAC activity, increase acetylation of H3 and H4, and inhibit cell cycle progression. It decrease pro-tumor markers (e.g., survivin, Bcl-2, c-Myc, mTOR, EGFR, VEGF) and promote apoptotic factors (e.g., bax, mcalpian, active caspase-3), and induced DNA fragmentation. There also occurs an increase in p21Waf1 expression, which is correlated with increased p53 expression and MDM2 degradation following DATS treatment 14. DATS also enhance the expression of Fas, p21, p53 and cyclin B1, but down regulated the expression of Akt, cyclin D1, MDM2 and Bcl-2) 14. DATS induce cell cycle inhibition and elevate levels of cyclin B1 and p21, and reduce levels of cyclin D1 in Capan-2 cells and H6C7 cells 30. DATS causes cytotoxicity which is mediated by the generation of ROS and subsequent activation of the ASK1-JNK-Bim signal transduction pathway in human breast carcinoma MDA-MB-231 cells 44. S-benzyl-cystein also-mediate cell cycle arrest and operate apoptosis that involves activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells 50. Tumor cells lacking p53 may continue to replicate damaged DNA and do not undergo apoptosis. Finally, cell cycle stalls in the cells with the damaged DNA.
DAS treatment of cultured cell also invokes changes typical of apoptosis such as morphological changes, DNA damage and fragmentation, dysfunction of mitochondria. It also induce cytochrome c release and increase expression of pro-caspase-3 and -9. DAS also promote the release of AIF and Endo G from mitochondria in HeLa cells 64. In fact G2/M checkpoint prevents cells containing damaged DNA from entering mitosis (M). Activated CDK1 (cdc2) bound to cyclin B promotes entry into M-phase. Wee1 and Myt1 kinases and cdc25 phosphatase competitively regulate CDK1 activity; Wee1 and Myt1 inhibit CDK1 and prevent entry into M-phase, while cdc25 removes inhibitory phosphates. DNA damage activates multiple kinases activity 68 mainly phosphorylate kinases Chk1/2 and tumor suppressor protein p53. Chk1/2 kinases stimulate Wee1 activity and inhibit cdc25C, preventing entry into M-phase 69. Phosphorylation of p53 promotes dissociation between p53 and MDM2 and allows binding of the transcription factor to DNA (Figure 1 and Figure 2). SFN Sulforaphane (SFN) and NaHS activated p38 mitogen-activated protein kinases (MAPK) and c-Jun N-terminal kinase (JNK) 70. Pre-treatment of PC-3 cells with methemoglobin decreased SFN-stimulated MAPK activities. DATS inhibits phosphatidylinositol 3'-kinase/Akt activation that, in turn, results in modulation of Bcl-2 family proteins, leading to enhanced apoptosis of T24 cells ) 38. Crushed garlic inhibit the proliferation of tumour cells by inducing G(2)/M cell cycle arrest and apoptosis) 71. Similarly, ajoene also inhibit WHCO1 cell growth, inducing G(2)/M cell cycle arrest and apoptosis by caspase-3 activation. Here, vinyl group serves to enhance the anti-proliferation activity manifold 71.
2.6. Pro-inflammatory Cytokine ProductionDADS inhibit the activation and nuclear translocation of p65, p50, and c-Rel subunits of nuclear factor (NF)-B and other transcription factors, such as c-fos, activated transcription factor-2, and cyclic adenosine monophosphate response element-binding protein, in B16F-10 melanoma cells 72. In also does down regulation of pro-inflammatory cytokine production and gene expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF). DADS induces caspase-dependent apoptosis through a mitochondria-mediated intrinsic pathway in B16F-10 melanoma cells by activating p53 and caspase-3 gene expression and suppressing pro-inflammatory cytokines and NF-B-mediated Bcl-2 activation 72. DADS treatment of colonic adenocarcinoma cells (HT-29) initiates a cascade of molecular events characteristic of apoptosis. These include a decrease in cellular proliferation, translocation of phosphatidylserine to the plasma-membrane outer-layer, activation of caspase-3 and -9, genomic DNA fragmentation, and G(2)/M phase cell-cycle arrest 56. Short-chain fatty acids (SCFAs), particularly butyrate (abundantly produced in the gut by bacterial fermentation of dietary polysaccharides), enhance colonic cell integrity but, in contrast, inhibit colonic cancer cell growth 56. Combining DADS with butyrate augmented the apoptotic effect of butyrate on HT-29 cells. More likely, anti-cancerous properties of DADS are of greater benefit when supplied with other favorable dietary factors (short chain fatty acids/polysaccharides) that likewise reduce colonic tumor development 56.
DATS-mediated G2/M phase cell cycle arrest was found to be independent of reduced complex formation between cdk1 and cyclin B1, but it is correlated with delayed nuclear translocation of cdk1. DATS-mediated G2/M phase cell cycle arrest in DU145 cells results in differential kinetics of nuclear localization of cdk1 and cyclin B1 73. DAS treatment increased the accumulation of sub-G1 DNA which also increases the proportion of cells in the G2/M phase in a dose-dependent manner. In addition, DAS-induced apoptosis shows a decrease in the level of Bcl-2 expression and an increase in the level of Bax expression, and cytochrome c was remarkably released from mitochondrial into the cytosol by DAS. Furthermore, caspase-9 and caspase-3 were activated by DAS, and DAS cleaved PARP. DAS decreases cell proliferation and induce apoptosis via mitochondrial signaling pathway in ATC cells 74. Here, both p38MAPK and caspase-3 are seems to be involved in the process of DADS-induced apoptosis in human HepG2 cells and interact with each other 75. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling 76.
2.7. Transcriptional Induction of p21DADS treatment causes significant transcriptional induction of p21 in early hours of treatment, which is due to increased nuclear translocation of NF-κB and its specific binding to p21 promoter. It also induce transient G2/M phase arrest, which in later hours is lost leading to apoptosis via intrinsic mitochondria-mediated pathway through generation of reactive oxygen species followed by changes in mitochondrial membrane potential 47. DADS induces reversible G2/M arrest through NF-κB mediated pathway in human leukemic cell lines, like U937, K562, and Jurkat, lacking wild type p53. However, failure of G2/M arrest make the system incapable of the damage repair system that leads to apoptosis 47. Similarly, BGE and radiotherapy combination significantly induce Lewis cells' apoptosis in G2/M stage which decreases the expression of bcl-2, and up-regulated the expression of bax 10. BGE sensitize the lung cancer Lewis cells to ionizing irradiation. This effect might be probably caused by changing the cell cycles and affecting expressions of bax and bcl-2 10.
Spindle check points 77 are important to repair DNA damage and cancer therapy 78 (Figure 1 and Figure 2). These checkpoints ensure proper chromatid attachment prior to progression from metaphase to anaphase. Similarly, both SCF and APC/C protein complexes play prominent roles, with APC-cdc20 initiating the entry into anaphase by promoting ubiquitin-mediated degradation of multiple substrates, including cyclin B 79. It indicates that regulatory proteins have important role in repairing of DNA level defects and occurrence of mutation in these proteins induce stressed in cancer prone cells. It is true that proteins like SCF and APC/C ubiquitin ligases also control cell growth 80. There occurs a mutual regulation between the spindle check point and APC/C 81. Organosulfur compounds modulate the activity of several metabolizing enzymes that activate (cytochrome P450s) or detoxify (glutathione S-transferases) carcinogens and inhibit the formation of DNA in different tissues 19.
Reactive oxygen species (ROS) are formed as a natural byproduct of the normal metabolism of oxygen and have important roles in cell signaling and homeostasis 82. These are also formed due to environmental stress mainly due to heat exposure, ionizing radiation 83, pollutants, tobacco, smoke, drugs and other agents. Their levels get increased dramatically if no antioxidant is used in the diet 82. ROS reactive intermediates cause significant damage to cell structure and function. ROS are also formed intracellularly through multiple mechanisms and effect NADPH oxidase (NOX) complexes found in cell membranes, mitochondria, peroxisomes, and endoplasmic reticulum 84, 85. Cancer cells show extremely high ROS levels that shows weaker antioxidant defense system. Further, cellular ROS stress level elevated due to over drug dosage and cut down tolerability threshold, a induce cell death. 86 (Kong et al., 2006). On the other hand, normal cells show lower cellular stress and show very high capacity to fight ROS and its related changes 87. Garlic chemical constituents showed very multiple therapeutic efficacy and are proved useful for preventing diseases associated with reactive oxygen species 88. Aged garlic extract scavenges superoxide radicals 91 and induce apoptosis in cancer cells 89, 90. Diallyl trisulfide does inhibition of cell proliferation and migration in cancer cells and acts as chemopreventive drug 91. The DATS-induced apoptosis in MDA-MB-231, MCF-7, and BRI-JM04 cells was found to be associated with reactive oxygen species (ROS) production 91. However, over expression of Cu, Zn-superoxide dismutase (Cu,Zn-SOD) as well as Mn-SOD conferred significant protection against DATS-induced ROS production and apoptotic cell death in MDA-MB-231 and MCF-7 cells. The DATS treatment caused ROS generation, but not activation of Bax or Bak, in MCF-10A cells. Furthermore, the DATS-mediated inhibition of cell migration was significantly attenuated by Cu,Zn-SOD and Mn-SOD over expression in association with changes in levels of proteins involved in epithelial-mesenchymal transition. The DATS-mediated induction of heme oxygenase-1 was partially attenuated by overexpression of Mn-SOD. There seems a critical role for ROS in anticancer effects of DATS 91. DATS also increases reactive oxygen species (ROS) production in primary colorectal cancer cells 43. Diallyl tetrasulfide acts independently of reactive oxygen species and tubulin represents one of its major cellular targets 42 (Kelkel et al., 2012). It induces production of reactive oxygen species (ROS) in normal cells similar to cancer cells in a time and dose dependent manner 92. This is the main reason that both garlic and its derivatives are used as conventional drug in many countries for clinical treatment of cancer 93.
Garlic derivatives such as ajoene, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB) 94 and show antiproliferative effects) 95. Allicin a sulfur compound breaks into diallyl disulfide (DADS) (66%), diallyl sulfide (DAS) (14%), diallyl trisulfide (9%), and sulfur dioxide 96. Allicin easily reacts with amino acids and proteins, creating a -SH group. It binds to protein and fatty acids in the plasma membrane, and is trapped before absorption. It circulate in the blood stream 97 but did not detect in the blood sample after the ingesting raw garlic or pure allicin 94. Allicin is metabolized into allyl methyl sulfoxide (AMS) and released into the breath after dietary intake 97. Allicin shows antitumoral activity in murine lymphoma L5178Y) 98 while DATS-induced apoptosis of human CNE2 cells 75 (Table 1). Allicin acts as an antioxidant in the blood and remove out all reactive oxygen species generated due to metabolic stress.
Garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation 99. These components also show induction of apoptosis in breast cancer cell lines 100, and did attenuation of cell migration and induction of cell death in rat sarcoma cells 101. The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis 102. Z-ajoene, a natural compound purified from garlic shows antimitotic and microtubule-interaction properties 103. A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A 104. More specifically, garlic preparations were found active against human tumor cell proliferation 105 and show antitumor 106 and anti-cancer effects 107. Allium vegetables in the daily diet play important role in the prevention of cancer 108 (Table 1) (Figure 5b).
There are so many extracellular agents such as ionizing radiation, UV light, environmental chemicals and alkyltaing agents which cause DNA damage in cells that finally induce carcinogenesis. Many potential therapies are used to target carcinogenesis through a series of alternatives including plant-derived pharmaceutical agents. A large number of these herbal remedies are particularly derived from garlic and are used to treat cancer patients mainly for inhibition of cancer cell proliferation and growth. DATS inhibits cell growth of human melanoma A375 cells and basal cell carcinoma (BCC) cells by increasing the levels of intracellular reactive oxygen species (ROS) and DNA damage. It also induce G2/M arrest, endoplasmic reticulum (ER) stress, and mitochondria-mediated apoptosis, including the caspase-dependent and -independent pathways 109. Similarly, DADS was found to be effective in inhibiting BaP-induced cell proliferation, cell cycle transitions, reactive oxygen species, and DNA damage in a normal cell line. It also inhibits environmentally induced breast cancer initiation 110. Diallyl polysulfides play potential role as chemopreventive and therapeutic agents in cancer treatment due to their selective antiproliferative effects.
Some herbal medicines including garlic show potentially beneficial effects against cancer progression and ameliorate chemotherapy-induced toxicities 111. As most of the anticancer drugs undergo Phase I and/or II metabolism and are substrates of P-glycoprotein, breast cancer resistance protein, multidrug resistance associated proteins, and/or other transporters. Therefore, induction and inhibition of these enzymes seems to be essential and mechanism of action of transporters is important for herb-anticancer drug interactions and action. However, endogenous mechanisms causing DNA damage such as spontaneous chemical hydrolysis, intracellular interaction with reactive oxygen groups and errors in replication and recombination can be restored by identifying correct and appropriate bio-molecules from garlic in form of a formulation (Figure 4). In addition chemical carcinogen induced changes such as depurination, de-amination, and reactive oxygen species including superoxide anion (an ion and a free radical) formation cab ne controlled by highly permeable oxygen bearing molecules from garlic. These compounds conjugated with certain cofactors and vitamins can finish reactive oxygen species formed by the effect of ionizing radiation. Both garlic oil and sulfur rich compounds can minimize the formation of free radicals due to oxidant reactions with proteins and other biomolecules. Diallyl sulfide (DAS), one of the main active constituents of garlic, causes growth inhibition of cancer cells in vitro and promotes immune responses in vivo 64.
Moreover, garlic based drugs or crude extracts prepared green garlic cloves induce apoptosis through the generation of reactive oxygen species in Hep3B human hepatocarcinoma cells 112. These also target DNA repair mechanisms, and do restoration of a series of metabolic and signaling pathways. Temperature- and pressure-treated green garlic does inhibition of ENNG-induced pyloric stomach and small intestinal carcinogenesis in mice 113. DNA damage also occurs due to mistakes in DNA replication or recombination cause strand breaks to be left in DNA. An incorrect proof reading also results in incorporation of mismatched bases. When damage occurs due to effect of carcinogens it remain repairable but long term natural genetic changes cannot be reverted. Possible potential anti-cancer agents from garlic such as diallyl trisulfide can check these events in eukaryotic cells due by imposing external stress on “checkpoints” of cell cycle. Drug may target effectively on proper timing of cellular events that can stop cell cycle or delay it. Thus, passage of anticarcinogenic effect through a checkpoint from one cell cycle phase will also require coordinated set of proteins that monitor cell growth and DNA integrity. Using natural products/molecules in a state of deficiency of transcription and translation of cell cycle proteins may activate DNA synthesis and protein translation. Garlic products can stop uncontrolled cell division or propagation of damaged DNA and save cells from genomic instability that give rise tumorigenesis (Figure 3). Diallyl trisulfide does transcriptional repression and inhibition of nuclear translocation of androgen receptor in human prostate cancer cells 114. It also inhibits estrogen receptor-α activity in human breast cancer cells 115 (Table 1). Thus garlic based herbal medicines have shown potentially beneficial effects on cancer progression and may ameliorate chemotherapy-induced toxicities (Figure 4).
DNA damage resulted in an impaired cellular response due to hypersensitivity generated by carcinogenic agents. If this DNA damage remains defective for longer period it results in mutations that lead to altered protein functions and generate impaired cellular responses. Normal cells react to DNA damage by stalling progress through the cell cycle at a check point until the damage has been repaired or triggering apoptosis if the damage remains un-reparable. All this is initiated by ATM protein briefly which sense DNA damage and relays the signal to the p53 protein which is synthesized under regulation of p53 gene that is known as the guardian of the genome 116. It plays a critical role in intrinsic tumor suppression via two mechanisms either through cell cycle arrest or by induction of apoptosis. A variety of triggers such as DNA damage, oncogene activation, and telomere erosion can lead to the activation of p53. An increase in p53 transcription inhibits cell cycling. Possibly p53 may be knocked out by mutation or by the action of an inhibitor such as the MDM2 gene product which binds p53 and targets for its degradation. S-Allylmercaptocysteine (CySSA) from garlic increases in phospho-p53, Bax and Bad levels which indicate that apoptosis occurs via the mitochondrial pathway 13 (Figure 4). SAMC-induced apoptosis is associated with the Id-1 pathway and that the inactivation of Id-1 enhances the ability of SAMC to inhibit the survival, invasion and migration of bladder cancer cells 117.
DADS induces apoptosis in the MCF-7 breast-cancer cell line through interfering with cell-cycle growth phases in a way that increases the sub-G(0) population and substantially halts DNA synthesis 56. It also induces phosphatidylserine translocation from the inner to the outer leaflet of the plasma membrane and activates caspase-3 56. It also modulates the cellular levels of Bax, Bcl-2, Bcl-xL, and Bcl-w in a dose-dependent manner, and show involvement of Bcl-2 family proteins in apoptosis 56. Diallyl trisulfide (DATS) induces apoptosis and inhibits the growth of many cancer cell lines. Mainly it induces apoptotic cell death in human primary colorectal cancer cells through a mitochondria-dependent caspase cascade signaling pathway through a significant decrease of the anti-apoptotic Bcl-2 that resulted in up-regulation of the ratio of Bax/Bcl-2 and the activity of caspase-3, -8, and -9 44, 46. It also increases in the levels of cytochrome c, Apaf-1, AIF and caspase-3 and caspase-9 activity 44. Eventually, DATS induce the apoptosis and inhibit the cancer cell proliferation in a concentration- and time-dependent manner 46. Exposure to DATS additionally induced endogenous endoplasmic reticulum stress markers and intracellular Ca2+ mobilization, upregulation of Bip/GRP78 and CHOP/GADD153, and activation of caspase-4 46. It also makes an increase in reactive oxygen species (ROS) production in primary colorectal cancer cells but decrease in the level of ΔΨm was associated with an increase in the Bax/Bcl-2 ratio which led to activation of caspase-9 and -3. No doubt, DATS can offer protection against chemically-induced neoplasia as well as oncogene-driven spontaneous cancer development in experimental animals. DATS do alteration in carcinogen-metabolizing enzymes, operate cell cycle arrest, and impose induction of apoptotic cell death, suppression of oncogenic signal transduction pathways, and inhibition of neoangiogenesis 118. DATS did not affect the activity of sulfurtransferases and lowered sulfane sulfur level in HepG2 cells. But is possible that sulfane sulfur containing DATS may be bioreduced in cancer cells to hydroperthiol that leads to H(2)O(2) generation, thereby influencing transmission of signals regulating cell proliferation and apoptosis 119. Similarly, allicin also inhibit the cell viability of U87MG human glioma cells in a dose- and time-dependent manner. Allicin-induced inhibition of cell viability was due to apoptosis of cells. The mechanisms of apoptosis were found to involve the mitochondrial pathway of Bcl-2/Bax, the MAPK/ERK signaling pathway and antioxidant enzyme systems 37 (Figure 4).
DATS also exerts chemopreventive potential via ER stress and the mitochondrial pathway in BCC cells 41. DAS, DADS, and DATS induce down regulation expression of PI3K, Ras, MEKK3, MKK7, ERK1/2, JNK1/2, and p38 and then lead to the inhibition of MMP-2, -7, and -9. DAS, DADS, and DATS inhibited NF-κB and COX-2 for leading to the inhibition of cell proliferation 120. DADS inhibit the activities of matrix metalloprotease (MMP)-2 and -9 in AGS cells in dose-dependent manner. It decreases expression of their mRNA and proteins and repressed the levels of claudin proteins (claudin-2, -3, and -4 121. In addition, both diallyl tri- and tetrasulfide are reported as strong inducers of an early mitotic arrest and subsequent apoptosis 42. Diallyl tetrasulfide acts independently of reactive oxygen species and tubulin represents one of its major cellular targets. Tubulin depolymerization prevents the formation of normal spindle microtubules, thereby leading to G2/M arrest. Moreover, c-jun N-terminal kinase, which is activated early in response to diallyl tetrasulfide treatment, mediates multisite phosphorylation and subsequent proteolysis of the anti-apoptotic protein B-cell lymphoma 2 42 (Figure 4).
SAC suppress the proliferation of PC-3 cells and led to cell cycle arrest at the G0/G1 phases, as well as inducing cell apoptosis which was accompanied by the decreased expression of Bcl-2 and increased expression of Bax and caspase 8 122. This chemopreventive effect of SAC may be associated with the suppression of carcinogenesis factors such as N-methylpurine DNA glycosylase and OPN. SAC also significantly suppresses the phosphorylation of Akt, mammalian target of rapamycin, inhibitor of κBα and extracellular signal-regulated kinase 1/2 in tumour tissues 122. But SAC-mediated suppression of cyclin D1 protein was associated with an augmented expression of the cell-cycle inhibitor p16(Ink4). SAC also inhibit expression of cyclo-oxygenase-2, vimentin and NF-κB p65 (RelA) 123. In addition, both SFN Sulforaphane (SFN) and NaHS activate p38 mitogen-activate protein kinases (MAPK) and c-Jun N-terminal kinase (JNK) 124. Thus, pre-treatment of PC-3 cells with methemoglobin decreases SFN-stimulated MAPK activities. Suppression of both p38 MAPK and JNK reversed H(2)S- or SFN-reduced viability of PC-3 cells. H(2)S mediates the inhibitory effect of SFN on the proliferation of PC-3 cells. Therefore, H(2)S-releasing diet or drug might be beneficial in the treatment of prostate cancer 124. SAC also hinder the migration and invasion of MHCC97L cells corresponding with up-regulation of E-cadherin and down-regulation of VEGF. It also significantly induced apoptosis and necrosis of MHCC97L cells through suppressing Bcl-xL and Bcl-2 as well as activating caspase-3 and caspase-9) 124, 125. In addition, SAC could significantly induce the S phase arrest of MHCC97L cells together with down-regulation of cdc25c, cdc2 and cyclin B1 125. Similarly, phytoalexins show specific targets in cancer cells that include signal transduction pathways, transcription factors, cell cycle checkpoints, intrinsic and extrinsic apoptotic pathways, cell invasion and matrix metalloproteinase, nuclear receptors, and the phase II detoxification pathway 126. Thiacremonone inhibits tumor growth accompanied with the reduction of PRDX6 expression and glutathione peroxidase activity, but its shows an increase in expression of cleaved caspase-3, -8, -9, Bax, p21 and p53) 21. Garlic extract induce cytotoxic and apoptotic effects in HL-60 cells that is mediated by oxidative stress 127, phosphatidylserine externalization, caspase-3 activation, and nucleosomal DNA fragmentation and formation of MDA, a by-product of lipid peroxidation and biomarker of oxidative stress 127 (Figure 4).
Diallyl trisulfide inhibits benzo(a)pyrene-induced precancerous carcinogenesis in MCF-10A cells 128 and induce apoptosis in human basal cell carcinoma cells via endoplasmic reticulum stress and the mitochondrial pathway 39. Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo 120 (Table 1). Diallyl trisulfide (DATS) is used to prevent growth of pancreatic 31 and prostate cancer cells PC-3) 129, and HCT116 cells 143. Diallyl trisulfide (DATS) inhibits mouse colon tumor in mouse CT-26 cells allograft model in vivo) 64. Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes 130. Diallyl sulfide inhibited murine WEHI-3 leukemia cells in BALB/c mice in vitro and in vivo 131 and induces molecular mechanisms which target cancer chemoprevention 132. It also induces Ca2+ mobilization in human colon cancer cell line SW480 133 (Table 1).
Fresh garlic extract induces growth arrest and morphological differentiation of MCF7 Breast cancer Cells 134. Sulfide compounds found in dietary garlic supplements 135 increase C reactive protein concentration 136 and enhance therapeutic potential against infectious agents 137. These effect cell proliferation, caspase 3 activities, thiol levels and anaerobic sulfur metabolism 119 and modulate peroxisome proliferation activated receptor gamma co-activator 1 alpha in human hepatoblastoma HepG2 cells 57. Garlic oil shows protective effects on hepatocarcinoma induced by N-nitrosodiethylamine in rats 138. Similarly, S-allylcysteine (SAC), a garlic derivative suppresses proliferation and metastasis of hepatocellular carcinoma 128 and induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells 122. Oxidative species and S-glutathionyl conjugates aids in the apoptosis induction by allyl thiosulfate 139.
The aged garlic extract (AGE) contains S-allyl-L-cysteine (SAC) which is a potential therapeutic agents for Alzheimer's disease 140. It is a major water- soluble compound found in aged garlic exerts cytotoxic activity by involving activation of mitochondrial-dependent apoptosis through p53 and Bax/Bcl-2 pathways in human gastric cancer SGC-7901 cells 44. It inhibits tumor progression and the epithelial-mesenchymal transition in mouse xenograft model of oral cancer 123. It also shows ameliorating effects against Aβ-induced neurotoxicity and cognitive impairment 141. It induces inhibition of gastric cancer cell growth in vitro and in vivo 39. Similarly, S-benzyl-cysteine (SBC) a structural analog of S-allylcysteine (SAC), mediates cell cycle arrest and apoptosis that involves activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells 42. S-allylmercaptocysteine (SAMC) shows potent therapeutic effect on human cancer cells by causing apoptosis 10, 142. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells 124. Garlic-derived allyl sulfides cause inhibition of skin cancer progression 39 (Wang et al., 2012) and show modifying effect on colon carcinogenesis in C57BL/6J-ApcMin/⁺ mice 143.
However, intake of fruits and vegetable reduce the risk of gastric cancer 144, 145 and restore health and reduces the chances of occurrence of physiological diseases 146. Both garlic and garlic-derived organic sulfur compounds are used for controlling breast cancer 147, 148. Besides, sulfur compounds garlic also contains saponins, flavonoids vitamins, minerals, hence daily consumption of garlic vegetables daily can lower down the risk of hematologic malignancies and other lifestyle diseases 149, 150, 151. Garlic dietary supplements also contain multivitamins and folic acid which show strong anticancer effects in breast cancer survivors 152. These lower down oxidative stress and induce apoptotic mechanisms in acute promyelocytic leukemia 127, 170. Green garlic shows cardioprotective effects 153 (Alkreathy et al., 2012) and is used as a complementary and alternative medicines for treatment of breast cancer 154. It shows potential beneficial effects in oncohematology 155 (Table 1).
Consumption of s-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model 156. Similarly, S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions 157. S-allylmercapto-L-cysteine shows anticancer activity in implanted tumor of human gastric cancer cell 44 (Table 1). S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type 158. There occurs a relationship between lipophilicity and inhibitory activity against cancer cell growth of nine kinds of alk(en)yl trisulfides with different side chains 159 (Table 1). Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice 160. Thiacremonone, a sulfur compound isolated from garlic, attenuates lipid accumulation partially mediated via AMPK activation in 3T3-L1 adipocytes 124. Artesunate combined with allicin shows synergistic anticancer effect in osteosarcoma cell line in vitro and in vivo 161. Moreover, garlic components showed antioxidant activity 172 inhibit fibrosarcoma tumor growth in BALB/c mice positive 163.
Oil-soluble compounds such as diallyl sulfide (DAS), diallyl disulfide (DADS), diallyl trisulfide (DATS) and ajoene are more effective than water-soluble compounds in protection against cancer. DADS, a major organosulfur compound derived from garlic, decrease carcinogen-induced cancers in experimental animals and inhibit the proliferation of various types of cancer cells. Its mechanisms of action include: the activation of metabolizing enzymes that detoxify carcinogens; suppression of the formation of DNA adducts; antioxidant effects; regulation of cell-cycle arrest; induction of apoptosis and differentiation; histone modification; and inhibition of angiogenesis and invasion 164. No doubt DAC inhibitory effects of garlic organosulfur compounds might play a role in primary cancer prevention at doses achievable by human diet. 165. However, the decrease of the peripheral total white blood cells (WBCs) count induced by CTX/radiation was significantly suppressed by GO co-treatment. No doubt, GO consumption may benefit for the cancer patients receiving chemotherapy or radiotherapy 160.
5.1. Inhibition of Cancer Cell Proliferation and InvasionDiallyl disulfide shows anti-invasive activity through tightening of tight junctions and display inhibition of matrix metalloproteinase activitiy in LNCaP prostate cancer cells 74. Diallyl trisulfide does inhibition of cell proliferation and migration in cancer cells and acts as chemopreventive drug 91. Similarly, natural tetrasulfides also show antiproliferative effect of in human breast cancer cells that is mediated through the inhibition of the cell division cycle 25 phosphatases 166. Garlic reduces the risk of colorectal polyps 167 and accelerates red blood cell turnover and splenic erythropoietic gene expression in mice 168. Boiled garlic does inhibition of 1, 2-dimethylhydrazine-induced mucin-depleted foci and O6-methylguanine DNA adducts in the rat colorectum 169 while crude garlic extract and its fractions showed cytotoxic effect 170 on malignant and nonmalignant cell lines 171. Garlic provides great protection against physiological threats 172 and lower downs risk of gastric cancer 10, 173. DAS also does growth inhibition and induce apoptosis in anaplastic thyroid cancer cells by mitochondrial signaling pathway 74 while allyl sulfur compounds causes cellular detoxification of carcinogens and is used in cancer therapy 174. Garlic phytochemicals counteract the cardiotoxic side effects of cancer chemotherapy 175 (Table 1). SAMC inhibit the survival, invasion and migration of bladder cancer cells 117.
Garlic derived natural products showed chemopreventive effects and successfully prevent colorectal, 11 and prostate cancer 176. These also show onco-cardiological prevention 177 reduce the risk of invasive cervical) 75 and ovarian carcinoma 16. Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells) 39 (Wang et al., 2010). Garlic powder supplemented diet shows chemopreventive effects in diethylnitrosamine-induced rat hepatocarcinogenesis) 178 (Figure 5a). It also shows chemoprotection against cyclophosphamide toxicity in mice 179 and protects against adriamycin induced alterations in mouse red blood cells (Thabrew et al., 2000) 180. Garlic inhibits methylcholanthrene-induced carcinogenesis in the uterine cervix of mice 181 and shows prevention of 4-nitroquinoline 1-oxide-induced rat tongue 182 and hamster cheek pouch carcinogenesis. It shows protective effects against bromobenzene toxicity to precision cut rat liver slices 183, 184. Diallyl disulfide shows prevention of chemically induced skin tumor development 185. Organosulfur compounds from garlic and onions protect from benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse 186 (Table 1). Onion and garlic oils and extracts inhibit tumor promotion in experimental animals 187, 188. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer 189.
Organosulfur compound isolated from garlic have been shown to have anticancer activity both in vitro and in vivo. These are also used as pharmaceuticals for treatment of acute and chronic diseases and are thought to be powerful instrument in maintaining health as medicine and nutraceutical. Garlic components do restoration of cell death pathways via the targeting of mitochondrial proteins. These can normalize the central pathway which can frequently impair cancer cells and contributes to the development of resistance to conventional chemotherapy. Garlic derived molecules can be formulated and designed to target oxidants or pro-oxidants and to activate pro-apoptotic proteins as well as to block these proteins. Garlic based herbal products and targeted molecules can find good solutions for clinical management of various cancer types. Today garlic based herbal medicines are attracting public health authorities, pharmaceutical industries because of its larger use in prevention and treatment of so many diseases and disorders. Garlic derived dietary supplements are highly demanded by nutritionists, physicians, food technologists and food chemists. No doubt garlic and its derived herbal products are providing optimal health and quality of life.
Author has no conflict of interests. The author alone is responsible for the content and writing of the paper.
Author is thankful to Prof. Ashok Kumar, Vice Chancellor, D D U Gorakhpur University, Gorakhpur for his kind support.
DAS=diallyl sulfide
DADS= diallyl disulfide
DATS= diallyl trisulfide
SBC=S-benzyl-cysteine
SAMC =S-allylmercaptocysteine
SAC =S-allylcysteine (SAC)
ROS =reactive oxygen species
BSO =buthionine sulfoximine
CySS=S-alkenylmercaptocysteine
caspase=cysteine-aspartic acid protease.
[1] | M.C. Rocio, and J. L. Rion, “A Review of Some Antimicrobial Substances Isolated from Medicinal Plants Reported in the Literature Review of Phytochemical Analysis on Garlic 1978-1972”. Phytother. Vol. 3, pp. 117-125. 1982. | ||
In article | |||
[2] | J.A. Alli, B.E. Boboye, I.O. Okonko, A.F. Kolade, J.C. Nwanze, “In-Vitro assessments of the effects of garlic (Allium sativum) extract on clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus”. Advances in Applied Science Research Vol. 2, pp. 25-36, 2011. | ||
In article | View Article | ||
[3] | E. Block, “The chemistry of garlic and onions”. Sci Am. Vol.252, no. 3, pp. 114-119, 1985. | ||
In article | View Article PubMed | ||
[4] | Y.L. Chu, R. Raghu, KH Lu, C.T. Liu, S.H. Lin, YS Lai, WC Cheng, SH Lin, LY Sheen, “Autophagy Therapeutic Potential of Garlic in Human Cancer Therapy”. J Tradit Complement Med. Vol. 3, no. 3, pp. 159-162, 2013. | ||
In article | View Article PubMed | ||
[5] | T. Zeng, Y. Li, CL Zhang, LH Yu, ZP Zhu, XL Zhao, KQ Xie, “Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice”. J Food Sci. Vol. 78, no. 6, pp. 936-42, 2013. | ||
In article | View Article PubMed | ||
[6] | Z.Y. Jin, M Wu, R.Q. Han, X.F. Zhang, X.S. Wang, A.M. Liu, J.Y. Zhou, Q.Y. Lu, Z.F. Zhang, J.K. Zhao, “Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese population”. Cancer Prev Res (Phila), Vol. 6, no. 7, pp. 711-8, 2013. | ||
In article | View Article PubMed | ||
[7] | B. Zhu, L. Zou, L. Qi, R. Zhong, X. Miao, “Allium Vegetables and Garlic Supplements do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies”. Clin Gastroenterol Hepatol. pii: S1542-3565, no. 14, pp. 00451-0. | ||
In article | View Article | ||
[8] | C.A. González, N.Travier, L. Luján-Barroso, X. Castellsagué, F.X. Bosch, E. Roura, H.B. Bueno-de-Mesquita, D. Palli, “Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study”. Int J Cancer. Vol. 129, no. 2, pp. 449-59. 2011. | ||
In article | View Article PubMed | ||
[9] | B. Aggarwal, S. Prasad, B. Sung, S. Krishnan, S.Guha, “Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature”. Curr Colorectal Cancer Rep. Vol. 9, no. 1, pp. 37-56, 2013. | ||
In article | View Article PubMed | ||
[10] | G.Q. Yang, D. Wang, Y.S. Wang, Y. Y. Wang, K. Yang, “Radiosensitization effect of black garlic extract on lung cancer cell line Lewis cells”. Zhongguo Zhong Xi Yi Jie He Za Zhi. Vol. 33, no. 8, pp. 1093-7, 2013. | ||
In article | PubMed | ||
[11] | D.H. Alpers, “Garlic and its potential for prevention of colorectal cancer and other conditions”. Curr Opin Gastroenterol. Vol. 25, no. 2, pp. 116-21, 2009. | ||
In article | View Article PubMed | ||
[12] | M. Dong, G. Yang, H. Liu, X. Liu, S. Lin, D. Sun, Y. Wang, “Aged black garlic extract inhibits HT29 colon cancer cell growth via the PI3K/Akt signaling pathway”. Biomed Rep. Vol. 2, no. 2, pp. 250-254, 2014. | ||
In article | PubMed PubMed | ||
[13] | W. Zhang, H. Xiao, K.L. Parkin, “Apoptosis in MCF-7 breast cancer cells induced by S-alkenylmercaptocysteine (CySSR) species derived from Allium tissues in combination with sodium selenite”. Food Chem Toxicol.68C, pp. 1-10, 2014. | ||
In article | View Article PubMed | ||
[14] | G.C. Wallace, C.P. Haar, W.A. Vandergrift, P. Giglio, Y.N. Dixon-Mah, A.K. Varma, S.K. Ray, S.J. Patel, N.L. Banik, A. Das, “Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition”. J Neurooncol. Vol. 114, no. 1, pp. 43-50, 2013. | ||
In article | View Article PubMed | ||
[15] | Nohara T, Fujiwara Y, Ikeda T, Murakami K, Ono M, Nakano D, Kinjo J. Cyclic sulfoxides garlicnins B2, B3, B4, C2, and C3 from Allium sativum. Chem Pharm Bull (Tokyo). Vol. 61, no. 7, pp. 695-9. 2013. | ||
In article | View Article | ||
[16] | E. Appel, A.Rabinkov, M. Neeman, F. Kohen, D. Mirelman, “Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma”. J Drug Target.Vol.19, no. 5, pp. 326-35, 2011. | ||
In article | View Article PubMed | ||
[17] | S.S. Shord, K. Shah, A. Lukose, “Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals”. Integr Cancer Ther. Vol. 8, no. (3), pp. 208-27, 2009. | ||
In article | View Article | ||
[18] | C.H.Kaschula, R. Hunter, M.I. Parker, “Garlic-derived anticancer agents: structure and biological activity of ajoene”. Biofactors. Vol. 36, no. 1, pp. 78-85, 2010. | ||
In article | View Article | ||
[19] | Omar S. H. Al-Wabel N. A. Organosulfuric compounds and possible mechanism of garlic in cancer. 2010; 18(1); 51-58. | ||
In article | View Article | ||
[20] | S. Quintero-Fabián, D. Ortuño-Sahagún, M. Vázquez-Carrera, R.I. López-Roa, “Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes”. Mediators Inflamm. 381815, 2013. | ||
In article | PubMed PubMed | ||
[21] | M. Jo, H.M. Yun, K.R. Park, M.H. Park, D.H. Lee, S.H. Cho, H.S. Yoo, Y.M. Lee, H.S. Jeong, Y. Kim ,J.K. Jung,B.Y. Hwang,M.K. Lee, N.D. Kim, S.B. Han, J.T. Hong, “Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6”. PLoS One. Vol. 9, no. 3, e91508, 2014. | ||
In article | View Article PubMed | ||
[22] | J.O. Ban, H.S. Lee, H.S. Jeong, S. Song, B.Y. Hwang, D.C. Moon, Y. Yoon, do, S.B. Han, J.T. Hong, “Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}” B. Mol Cancer Res. Vol. 7, no.6, pp. 870-9, 2009. | ||
In article | View Article PubMed | ||
[23] | N.J. Shaheen, C. Hur, “Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus”. Gastroenterology. Vol. 145, no. 2, pp. 273-6, 2013. | ||
In article | View Article PubMed | ||
[24] | C. Busch, C. Jacob, A. Anwar, T. Burkholz, L. Aicha, Ba, C. Cerella, M. Diederich, W. Brandt, L. Wessjohann, M. Montenarh, “Diallylpolysulfides induce growth arrest and apoptosis”. Int J Oncol. Vol. 36, no.3, pp.743-9, M., 2010. | ||
In article | View Article | ||
[25] | E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, J. Yuan, “Human ICE/CED-3 protease nomenclature”. Vol. 87, no. 2, pp. 171, 1996. | ||
In article | View Article | ||
[26] | Entrez Gene: CASP3 caspase 3, apoptosis-related cysteine peptidase. | ||
In article | |||
[27] | S. Ghavami, M. Hashemi, S.R. Ande, B. Yeganeh, W. Xiao, M. Eshraghi, C.J. Bus, K. Kadkhoda, E. Wiechec, A.J. Halayko, M. Los, “Apoptosis and cancer: mutations within caspase genes”. J. Med. Genet. Vol. 46, no. 8, pp. 497-510, 2009. | ||
In article | View Article PubMed | ||
[28] | D.Y. Shin, H.J. Cha, G.Y. Kim, W.J. Kim, Y.H. Choi, “Inhibiting invasion into human bladder carcinoma 5637 cells with diallyl trisulfide by inhibiting matrix metalloproteinase activities and tightening tight junctions”. Int J Mol Sci. Vol. 14, no. 10, pp.19911-22, 2013. | ||
In article | View Article PubMed | ||
[29] | H. Vakifahmetoglu-Norberg, B. Zhivotovsky, “The unpredictable caspase-2: what can it do?” Trends Cell Biol. Vol. 20, pp.150-159, 2010 . | ||
In article | View Article PubMed | ||
[30] | H.B. Ma, S. Huang, X.R. Yin, Y. Zhang, Z.L. Di. “Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells”. World J Gastroenterol. Vol. 20, no. (1), pp. 193-203, 2014. | ||
In article | |||
[31] | N.N. Danial, S.J. Korsmeyer, “Cell death: critical control points” Cell. Vol. 116, pp. 205-219, 2004. | ||
In article | View Article | ||
[32] | J.F. Kerr, A.H. Wyllie, A.R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics”, Br. J. Cancer, Vol. 26, pp. 239-257, 1972. | ||
In article | View Article PubMed | ||
[33] | J.C. Reed, “Bcl-2 family proteins”, Oncogene Vol. 17, pp. 3225-3236, 1998. | ||
In article | View Article PubMed | ||
[34] | X. Lan, H. Sun, J. Liu, Y. Lin, Z. Zhu, X. Han, X. Sun, X. Li, H. Zhang, Z. Tang, “Effects of garlic oil on pancreatic cancer cells”. Asian Pac J Cancer Prev. Vol.14, no. 10, pp. 5905-10, 2013. | ||
In article | View Article PubMed | ||
[35] | Z. Xu, H. Wang, Y. Chen, G. Mao, Y. Hu, T. Zeng, K. Xie, “Preventive effects of garlic oil against the benzene-induced hematotoxicity in mice”. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. Vol. 32, no. 5, pp. 373-5, 2014. | ||
In article | PubMed | ||
[36] | H.K. Na, E.H. Kim, M.A. Choi, J.M. Park, D.H. Kim, Y.J. Surh, “Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1”. Biochem Pharmacol. Vol. 84, no. 10, pp. 1241-50, 2012. | ||
In article | View Article PubMed | ||
[37] | J.H. Cha, Y.J. Choi, S.H. Cha, C.H. Choi, W.H. Cho, “Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway”. Oncol Rep. Vol. 28, no. 1, pp. 41-8, 2012. | ||
In article | View Article | ||
[38] | Y.L. Chu, C.T. Ho, J.G. Chung, R. Rajasekaran, L.Y. Sheen, “Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells”. J Agric Food Chem. Vol. 60, no. 34, pp. 8363-71, 2012. | ||
In article | View Article PubMed | ||
[39] | Y.B. Wang, J. Qin, X.Y. Zheng, Y. Bai, K. Yang, L.P. Xie, “Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells”. Phytomedicine. Vol. 17, no. 5, pp. 363-8, 2010. | ||
In article | View Article PubMed | ||
[40] | W. Zhang, M. Ha, Y. Gong, Y. Xu, N. Dong, Y. Yuan, “Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways”. Oncol Rep. Vol. 24, no. 6, pp. 1585-92, 2010. | ||
In article | PubMed | ||
[41] | W. Bat-Chen, T. Golan, I. Peri, Z, Ludmer, B. Schwartz, “Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2.” Nutr Cancer. Vol. 62(7), pp. 947-57, 2010. | ||
In article | View Article PubMed | ||
[42] | M. Kelkel, C. Cerella, F. Mack, T. Schneider, C. Jacob, M. Schumacher, M. Dicato, M. Diederich, “ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis”. Carcinogenesis. Vol. 33, no. 11, pp. 2162-71, 2012. | ||
In article | View Article PubMed | ||
[43] | C.S.Yu, A.C. Huang, K.C. Lai, Y.P. Huang, M.W. Lin, J.S. Yang, J.G. Chung, “Diallyl trisulfide induces apoptosis in human primary colorectal cancer cells”. Oncol Rep. Vol. 28, no. 3, pp. 949-54, 2012. | ||
In article | PubMed | ||
[44] | Y. Lee, H. Kim, J. Lee, K. Kim, “Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell’. Biol Pharm Bull. Vol. 34, no. 5, pp. 677-81, 2011. | ||
In article | View Article PubMed | ||
[45] | M. Murai, T. Inoue, M. Suzuki-Karasaki, T. Ochiai, C. Ra , S. Nishida, Y. Suzuki-Karasaki, “Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis”. Int J Oncol. Vol. 41, no. 6, pp. 2029-37, 2012. | ||
In article | PubMed | ||
[46] | L. Li, T. Sun, J. Tian, K. Yang, K. Yi, P. Zhang, “Garlic in clinical practice: an evidence-based overview”. Crit Rev Food Sci Nutr. Vol. 53, no. 7, pp. 670-81, 2013. | ||
In article | View Article PubMed | ||
[47] | P. Dasgupta, S.S. Bandyopadhyay, “Role of di-allyl disulfide, a garlic component in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines”. Nutr Cancer. Vol. 65, no. 4, pp. 611-22, 2013. | ||
In article | View Article PubMed | ||
[48] | Malki A, El-Saadani M, Sultan AS. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol Ther. 2009; 8(22): 2175-85. | ||
In article | View Article PubMed | ||
[49] | Knowles, L.M., Milner, J.A., 2001. Possible mechanism by which allyl sulfides suppress neoplastic cell proliferation. J Nutr.; Vol. 131, no. 3s, 1061S-1066S. | ||
In article | PubMed | ||
[50] | H.J. Sun, L.Y. Meng, Y. Shen ,Y.Z. Zhu, H.R. Liu, “S-benzyl-cysteine-mediated cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells”. Asian Pac J Cancer Prev. Vol. 14, no.11, pp. 6379-84, 2013. | ||
In article | View Article PubMed | ||
[51] | T.A. Miller, J.Witter, David, S. Belvedere, “Histone Deacetylase Inhibitors”. Journal of Medicinal Chemistry, Vol. 46, no. 24, pp. 5097-116, 2003. | ||
In article | View Article PubMed | ||
[52] | Mwakwari, Sandra., V. Patil, W. Guerrant, A. Oyelere, “Macrocyclic Histone Deacetylase Inhibitors”. Current Topics in Medicinal Chemistry Vol. 10, no. (14), pp. 1423-40, 2010. | ||
In article | View Article | ||
[53] | V. Patil, Guerrant., William Chen., C. Po, B. Gryder, Benicewicz, B. Derek, Khan, I. Shabana, Tekwani, L. Babu, Oyelere, K. Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol.18, pp. 415-425, 2010. | ||
In article | View Article PubMed | ||
[54] | Druesne-Pecollo N, Latino-Martel P. Modulation of histone acetylation by garlic sulfur compounds. Anticancer Agents Med Chem. Vol.11, no. 3, pp. 254-9. 2011. | ||
In article | View Article PubMed | ||
[55] | A.C. Chueh, J.W. Tse, L. Tögel, J.M. Mariadason, “Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells”. Antioxidants & Redox Signaling, Vol. 23, no. 1, pp. 66-84. | ||
In article | View Article | ||
[56] | M.O. Altonsy, S.C. Andrews, “Diallyl disulphide, a beneficial component of garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29)”. Nutr Cancer, Vol. 63, no. (7), pp. 1104-13, 2011. | ||
In article | View Article | ||
[57] | B. Pagliei, K. Aquilano, S. Baldelli, M.R. Ciriolo, “Garlic-derived diallyl disulfide modulates peroxisome proliferator activated receptor gamma co-activator 1 alpha in neuroblastoma cells”. Biochem Pharmacol. Vol. 85, no. 3, pp. 335-44, 2013. | ||
In article | View Article PubMed | ||
[58] | Malumbres, Marcos; M. Barbacid, “Cell cycle, CDKs and cancer: a changing paradigm”. Nature Reviews Cancer, Vol. 9, PP. 153-166, 2009. | ||
In article | View Article | ||
[59] | Julian Lewis, 2007. “Molecular biology of the cell “(5th ed.). New York: Garland Science. | ||
In article | |||
[60] | K. Vermeulen, Van Bockstaele., R. Dirk, Berneman, N. Zwi, “The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer”. Cell Proliferation, Vol. 36, no. 3, pp. 131-149, 2003. | ||
In article | View Article PubMed | ||
[61] | Herman-Antosiewicz, et al, “Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1”. Pharm Res. Vol. 27, no. 6, pp. 1072-9, 2010. | ||
In article | View Article PubMed | ||
[62] | B. Czepukojc, A.K. Baltes, C. Cerella, M. Kelkel, U.M. Viswanathan, F. Salm, T. Burkholz, C.Schneider, M. Dicato, M. Montenarh, C. Jacob, M. Diederich, “Synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells”. Food Chem Toxicol. Vol. 64, pp. 249-57, 2014. | ||
In article | View Article PubMed | ||
[63] | A. Arunkumar, M.R. Vijayababu, N. Srinivasan, M.M. Aruldhas, J. Arunakaran, “Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3”. Mol Cell Biochem. Vol. 288, no. 1-2, pp. 107-113, 2006. | ||
In article | View Article PubMed | ||
[64] | P.P. Wu, H.W. Chung, K.C. Liu, R.S. Wu, J.S. Yang, N.Y. Tang, C. Lo, T.C. Hsia, C.C. Yu, F.S. Chueh, S.S. Lin, J.G. Chung, “Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways”. Int J Oncol. Vol. 38, no. 6, pp. 1605-13, 2011. | ||
In article | PubMed | ||
[65] | Y.L. Chu, C.T. Ho, J.G. Chung, R. Raghu, Y.C. Lo, L.Y. Sheen, “Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy”. J Agric Food Chem. Vol. 61, no. 41, pp. 9839-48, 2013. | ||
In article | View Article PubMed | ||
[66] | S. van den Heuvel, N.J. Dyson, “Conserved functions of the pRB and E2F families”. Nat. Rev. Mol. Cell Biol. Vol. 9, pp. 713-24, 2008. | ||
In article | View Article PubMed | ||
[67] | K.A. Cimprich, D. Cortez, “ATR: an essential regulator of genome integrity”. Nat. Rev. Mol. Cell Biol. Vol. 9, pp. 616-27, 2008. | ||
In article | View Article PubMed | ||
[68] | H.C. Reinhardt, M.B. Yaffe, “Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2”. Curr. Opin. Cell Biol. Vol. 21, pp. 245-55, 2009. | ||
In article | View Article PubMed | ||
[69] | Lindqvist, A., Rodrìguez-Bravo, V., Medema R.H., 2009. “The decision to enter mitosis: feedback and redundancy in the mitotic entry network”. J. Cell Biol. 185, vol.2, 193-202. | ||
In article | View Article | ||
[70] | V. Pei Patil, Guerrant., William Chen., C. Po, B. Gryder., Benicewicz, B. Derek, Khan, I. Shabana, L. Tekwani, Babu, Oyelere, K. Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol. 18, pp. 415-425, 2010. | ||
In article | View Article PubMed | ||
[71] | Kaschula CH, Hunter R, Stellenboom N, Caira MR, Winks S, Ogunleye T, Richards P, Cotton J, Zilbeyaz K, Wang Y, Siyo V, Ngarande E, Parker MI. Structure-activity studies on the anti-proliferation activity of ajoene analogues in WHCO1 oesophageal cancer cells. Eur J Med Chem.Vol.50, pp. 236-54, 2012 | ||
In article | View Article PubMed | ||
[72] | P. Pratheeshkumar, P. Thejass, G. Kutan, “Diallyl disulfide induces caspase-dependent apoptosis via mitochondria-mediated intrinsic pathway in B16F-10 melanoma cells by up-regulating p53, caspase-3 and down-regulating pro-inflammatory cytokines and nuclear factor-κβ-mediated Bcl-2 activation”. J Environ Pathol Toxicol Oncol. Vol. 29, pp. 113-25, 2010. | ||
In article | View Article PubMed | ||
[73] | Herman-Antosiewicz, “Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1”. Pharm Res. Vol. 27, pp. 1072-9, 2010. | ||
In article | View Article PubMed | ||
[74] | D.Y. Shin, G.Y. Kim, J.I. Kim, M.K. Yoon, T.K. Kwon, S.J. Lee, Y.W. Choi, H.S. Kang, Y.H. Yoo, Y.H. Choi, “Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells”. Toxicol In Vitro. Vol. 24, pp. 1569-76, 2010. | ||
In article | View Article PubMed | ||
[75] | Ji C, Ren F, Xu M. Caspase-8 and p38MAPK in DATS-induced apoptosis of human CNE2 cells. Braz J Med Biol Res. 2010; 43(9): 821-7. | ||
In article | View Article PubMed | ||
[76] | Shrotriya S, Kundu JK, Na HK, Surh YJ. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling. Cancer Res. 2010; 70(5): 1932-40. | ||
In article | View Article PubMed | ||
[77] | A. Musacchio, “Spindle assembly checkpoint: the third decade”. Philos. Trans. R. Soc. Lond., B, Biol. Sci. Vol. 366, no. 1584, pp. 3595-604, 2011 | ||
In article | View Article PubMed | ||
[78] | C.J. Lord, A. Ashworth, “The DNA damage response and cancer therapy”. Nature Vol. 481, no. 7381, pp.287-94, 2012. | ||
In article | View Article PubMed | ||
[79] | L. Wohlbold, R.P. Fisher “Behind the wheel and under the hood: functions of cyclin-dependent kinases in response to DNA damage”. DNA Repair (Amst.) Vol. 8, pp.1018-24, 2009. | ||
In article | View Article PubMed | ||
[80] | J.R. Skaar, M. Pagano, “Control of cell growth by the SCF and APC/C ubiquitin ligases”. Curr. Opin. Cell Biol. Vol. 21, pp. 816-24, 2009. | ||
In article | View Article PubMed | ||
[81] | S. Kim, H. Yu, “Mutual regulation between the spindle checkpoint and APC/C’. Semin. Cell Dev. Biol. Vol. 22, pp. 551-8, 2011. | ||
In article | View Article PubMed | ||
[82] | T. Devasagayam, J.C. Tilak, K.K. Boloor, Sane, S. Ketaki, S. Ghaskadbi Saroj, R.D. Lele, “Free Radicals and Antioxidants in Human Health: Current Status and Future Prospects”. Journal of Association of Physicians of India (JAPI) Vol. 52, pp. 796, 2004. | ||
In article | View Article | ||
[83] | M.E. Sosa Torres, J.P. Saucedo-Vázquez, P.M. Kroneck, Chapter 1, Section 3 The dark side of dioxygen”. In Kroneck PM, Torres ME. Sustaining Life on Planet Earth: Metalloenzymes Mastering Dioxygen and Other Chewy Gases. Metal Ions in Life Sciences 15. Springer. pp. 1-12, 2015. | ||
In article | |||
[84] | F. Muller, “The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging”. Journal of the American Aging Association Vol. 23, pp. 227-53, 2000. | ||
In article | View Article | ||
[85] | D. Han, E. Williams, E. Cadenas, “Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space”. The Biochemical Journal Vol. 353, pp. 411-6, 2001. | ||
In article | View Article PubMed | ||
[86] | Q. Kong, J.A. Beel, K.O. Lillehei, “A threshold concept for cancer therapy”. Medical Hypotheses Vol. 55, pp. 29-35, 2000. | ||
In article | View Article PubMed | ||
[87] | D. Trachootham, J. Alexandre, P. Huang, “Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?”. Nature Reviews. Drug Discovery. Vol.8, no. 7, pp. 579-91, 2009. | ||
In article | View Article PubMed | ||
[88] | N. Morihara, M. Hayama, H. Fujii, “Aged garlic extract scavenges superoxide radicals”. Plant Foods Hum Nutr. Vol. 66, pp. 17-21, 2011. | ||
In article | View Article PubMed | ||
[89] | K. Srinivasan, “Antioxidant potential of spices and their active constituents”. Crit Rev Food Sci Nutr. Vol. 54, no. 3, pp. 352-72, 2014. | ||
In article | View Article PubMed | ||
[90] | Capasso A. Antioxidant action and therapeutic efficacy of Allium sativum L. Molecules. Vol. 18, no. 1, pp. 690-700, 2013. | ||
In article | View Article PubMed | ||
[91] | K. Chandra-Kuntal, J. Lee, S.V. Singh, “Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic”. Breast Cancer Res Treat. Vol.138, pp. 69-79, 2013. | ||
In article | View Article PubMed | ||
[92] | Saidu NE, Abu Asali I, Czepukojc B, Seitz B, Jacob C, Montenarh M. Comparison between the effects of diallyl tetrasulfide on human retina pigment epithelial cells (ARPE-19) and HCT116 cells. Biochim Biophys Acta.; Vo. 1830, no. 11, pp. 5267-76. 2013. | ||
In article | View Article PubMed | ||
[93] | A. Djuv, O.G. Nilsen, A. Steinsbekk, “The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study”. BMC Complement Altern Med. Vol. 13, pp. 295, 2013. | ||
In article | View Article PubMed | ||
[94] | V.M. Dirsch, A.L. Gerbes, A.M. Vollmar, “Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB”. Mol Pharmacol. Vol. 53, no. 3, pp. 402-407, 1998. | ||
In article | PubMed | ||
[95] | Pinto JT, Rivlin RS. Antiproliferative effects of allium derivatives from garlic. J Nutr. Vol. 131, no. 3s, pp. 1058S-60S., 2001. | ||
In article | PubMed | ||
[96] | G.J. Blake, P.M. Ridker, K.M. Kuntz, “Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia”. Am J Med. Vol. 114, no.6, pp. 485-94, 2003. | ||
In article | View Article | ||
[97] | M. Ali, M. Thomson, M. Afzal, “Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance”. Prostaglandins Leukot Essent Fatty Acids. Vol.62, no. 2: pp. 55-73, 2000. | ||
In article | View Article PubMed | ||
[98] | E. Padilla-Camberos, G. Zaitseva, C. Padill, a, A.M. Puebla, “Antitumoral activity of allicin in murine lymphoma L5178Y”. Asian Pac J Cancer Prev. Vol. 11, no. 5, pp. 1241-4, 2010. | ||
In article | PubMed | ||
[99] | D. Xiao, J.T. Pinto, J.W. Soh, “Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation”. Cancer Res; Vol. 63, no. (20), pp. 6825-6837, 2003. | ||
In article | View Article | ||
[100] | R. Bradley, J. Endres, D. Hockenberry, “Investigation of garlic-induced apoptosis in breast cancer cell lines”. International Scientific Conference on Complementary, Alternative and Integrative Medicine Research, Boston, MA., 2002. | ||
In article | |||
[101] | Hu X, Cao BN, Hu G, et al. Attenuation of cell migration and induction of cell death by aged garlic extract in rat sarcoma cells. Int J Mol Med 2002; Vol. 9, 6, pp. 641-643. | ||
In article | View Article | ||
[102] | C.M. Tilli, A.J. Stavast-Kooy, J.D. Vuerstaek, “The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis”. Arch Dermatol Res, vol. 295, no. (3), pp. 117-123, 2003. | ||
In article | View Article | ||
[103] | M. Li, J.R. Ciu, Y. Ye, “Antitumor activity of Z-ajoene, a natural compound purified from garlic: antimitotic and microtubule-interaction properties”. Carcinogenesis. Vol. 23, no. 4, pp. 573-579, 2002. | ||
In article | View Article PubMed | ||
[104] | N. Morioka, L.L. Sze, D.L. Morton, “A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A”. Cancer Immunol Immunother; Vol. 37, no. 5, pp. 316-322, 1993. | ||
In article | View Article PubMed | ||
[105] | C.P. Siegers, B. Steffen, A. Robke, “The effects of garlic preparation against human tumour cell proliferation”. Phytomedicine Vol. 6, no. (1), pp.7-11, 1999. | ||
In article | View Article | ||
[106] | J.A. Milner, “Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlicand carcinogenesis”. Adv Exp Med Biol. Vol. 492, pp. 69-81, 2001. | ||
In article | View Article PubMed | ||
[107] | B.H. Lau, P.P. Tadi, J.M. Tosk, “Allium sativum (garlic) and cancer prevention”. Nutrit Res Vol. 10, pp. 937-948, 1990. | ||
In article | View Article | ||
[108] | M.J. Wargovich, N. Uda, C.Woods, “Allium vegetables: their role in the prevention of cancer”. B2iochem Soc Transl Vol. 24, no. 3, pp. 811-814, 1996. | ||
In article | View Article | ||
[109] | Z. Wang, Z. Liu, Z. Cao, L. Li, “Allicin induces apoptosis in EL-4 cells in vitro by activation of expression of caspase-3 and -12 and up-regulation of the ratio of Bax/Bcl-2”. Nat Prod Res. Vol. 26, no. 11, pp. 1033-7, 2012. | ||
In article | View Article PubMed | ||
[110] | Y.M. Nkrumah-Elie, J.S. Reuben , A.M. Hudson, E. Taka, R. Badisa, T. Ardley, B. Israel, S.Y. Sadrud-Din, E.T. Oriaku, S.F. Darling-Reed, “The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells”. Nutr Cancer. Vol. 64, no. 7, pp. 1112-21, 2012. | ||
In article | View Article PubMed | ||
[111] | A.K. Yang, S.M. He, L. Liu, J.P. Liu, M.Q. Wei, S.F. Zhou, “Herbal interactions with anticancer drugs: mechanistic and clinical considerations”. Curr Med Chem. Vol. 17, no. 16, pp. 1635-78, 2010. | ||
In article | View Article PubMed | ||
[112] | E.J. Kim, D.H. Lee, H.J. Kim, S.J. Lee, J.O. Ban, M.C. Cho, H.S. Jeong, Y. Yang, J.T. Hong, Y. Yoon, do, “Thiacremonone, a sulfur compound isolated from garlic, attenuates lipid accumulation partially mediated via AMPK activation in 3T3-L1 adipocytes”. J Nutr Biochem. Vol. 23, no. 12, pp. 1552-8, 2012. | ||
In article | View Article PubMed | ||
[113] | T. Kaneko, K. Shimpo, T. Chihara, H. Beppu, A. Tomatsu, M. Shinzato, T. Yanagida, T. S. Sonoda, A. Futamura, A. Ito, T.Higashiguchi, “Inhibition of ENNG-induced pyloric stomach and small intestinal carcinogenesis in mice by high temperature- and pressure-treated garlic”. Asian Pac J Cancer Prev. Vol. 13, no. 5, pp. 1983-8, 2012. | ||
In article | View Article PubMed | ||
[114] | S.D. Stan, S.V. Singh, “Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide inhuman prostate cancer cells”. Clin Cancer Res. Vol. 15, no. 15, pp. 4895-903, 2009. | ||
In article | View Article PubMed | ||
[115] | E.R. Hahm, S.V. Singh, “Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells”. Breast Cancer Res Treat. Vol. 144, no. 1, pp. 47-57, 2014. | ||
In article | View Article PubMed | ||
[116] | D.P. Lane, “Cancer. p53, guardian of the genome”, Nature, Vol. 358, pp. 15-16, 1992. | ||
In article | View Article PubMed | ||
[117] | H. Hu, X.P. Zhang, Y.L. Wang, C.W. Chua, S.U. Luk, Y.C. Wong, M.T. Ling, X.F. Wang, K.X. Xu, “Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells”. Mol Med Rep. Vol. 4, no. 1, pp. 9-16, 2011. | ||
In article | PubMed | ||
[118] | M.L. Antony, S.H. Kim, S.V. Singh, “Critical role of p53 upregulated modulator of apoptosis in benzyl isothiocyanate-induced apoptotic cell death”. PLoS One. Vol. 7, no. 2:e32267, 2012. | ||
In article | View Article PubMed | ||
[119] | M. Iciek, I. Kwiecień, G. Chwatko, M. Sokołowska-Jeżewicz, D. Kowalczyk-Pachel, H. Rokita, “The effects of garlic-derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells”. Cell Biochem Funct. Vol. 30, no. 3, pp. 198-204, 2012. | ||
In article | View Article PubMed | ||
[120] | Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu HF, Tang NY, Hsia TC, Ho HC, Chung JG. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions. Environ Toxicol. Vol. 28, no. 9: 479-88. | ||
In article | View Article PubMed | ||
[121] | H.S. Park, G.Y. Kim, I.W. Choi, N.D. Kim, H.J. Hwang, Y.W. Choi, Y.H. Choi, “Inhibition of matrix metalloproteinase activities and tightening of tight junctions by dially l disulfide in AGS human gastric carcinoma cells”. J Food Sci. Vol. 76, no. 4, pp. 105-11, 2011. | ||
In article | View Article PubMed | ||
[122] | Z. Liu, M. Li , K. Chen ,J. Yang , R. Chen ,T. Wang, J. Liu , W. Yang , Z. Ye. S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells. Mol Med Rep. Vol. 5, no. 2, pp. 439-43, 2012. | ||
In article | PubMed | ||
[123] | M.H. Pai, Y.H. Kuo, E.P. Chiang, F.Y. Tang, “S-Allylcysteine inhibits tumour progression and the epithelial-mesenchymal transition in a mouse xenograft model of oral cancer”. Br J Nutr. Vol. 108, no. 1, pp. 28-38, 2012 | ||
In article | View Article PubMed | ||
[124] | V. Pei Patil, Guerrant, William Chen., C. Po, B. Gryder., Benicewicz, B. Derek, Khan, I.Shabana, Tekwani, L.Babu, Oyelere, K.Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol.18, pp. 415-425, 2010. | ||
In article | View Article PubMed | ||
[125] | K.T. Ng, D.Y. Guo, Q. Cheng, W. Geng, C.C. Ling, C.X. Li, X.B. Liu, Y.Y. Ma, C.M. Lo, R.T. Poon, S.T. Fan, K. Man, “A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma”. PLoS One. Vol. 7, no. 2, e31655, 2012. | ||
In article | View Article PubMed | ||
[126] | D.F. Romagnolo, CD Davis, JA Milner, “Phytoalexins in cancer prevention”. Front Biosci (Landmark Ed). Vol. 17, pp. 2035-58, 2012. | ||
In article | View Article | ||
[127] | C.G. Yedjou, P.B. Tchounwou, “In vitro assessment of oxidative stress and apoptotic mechanisms of garlic extract in the treatment of acute promyelocytic leukemia”. J Cancer Sci Ther. (Suppl 3) 6, 2012. | ||
In article | |||
[128] | Y.M. Nkrumah-Elie, J.S. Reuben, A.M. Hudson, E. Taka, R. Badisa, T. Ardley, B. Israel, S.Y. Sadrud-Din, E.T. Oriaku, S.F. Darling-Reed, “The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells”. Nutr Cancer. Vol. 64, no. 7, pp. 1112-21, 2012. | ||
In article | View Article PubMed | ||
[129] | A. Borkowska, N. Knap, J. Antosiewicz, “Diallyl trisulfide is more cytotoxic to prostate cancer cells PC-3 than to noncancerous epithelial cell line PNT1A: a possible role of p66Shc signaling axis”. Nutr Cancer. Vol. 65, no. 5, pp. 711-7, 2013. | ||
In article | View Article PubMed | ||
[130] | Y.S. Huang, N. Xie, Q. Su, J. Su, C. Huang, Q.J. Liao, “Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes”. Mol Med Rep. Vol. 4, no. 3, pp. 553-9, 2011. | ||
In article | PubMed | ||
[131] | F.S. Yu, C.C. Wu, C.T. Chen, S.P. Huang, J.S. Yang, Y.M. Hsu, P.P. Wu, S.W. Ip, J.P. Lin, J.G. Lin, J.G. Chung, “Diallyl sulfide inhibits murine WEHI-3 leukemia cells in BALB/c mice in vitro and in vivo”. Hum Exp Toxicol. Vol. 12, pp. 785-90, 2009. | ||
In article | View Article PubMed | ||
[132] | M.L. Antony, S.V. Singh, “Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide”. Indian J Exp Biol. Vol. 49, no. 11, pp. 805-16. 2011. | ||
In article | PubMed PubMed | ||
[133] | C.Y. Chen, C.F. Huang, Y.T. Tseng, S.Y. Kuo, “Diallyl disulfide induces Ca2+ mobilization in human colon cancer cell line SW480”. Arch Toxicol. Vol. 86, no. 2, pp. 231-8, 2012. | ||
In article | View Article PubMed | ||
[134] | S. Modem, S.E. Dicarlo, T.R. Reddy, “Fresh Garlic Extract Induces Growth Arrest and Morphological Differentiation of MCF7 Breast Cancer Cells”. Genes Cancer.Vol. 3, no. 2, pp. 177-86, 2012. | ||
In article | View Article PubMed | ||
[135] | K. Kashfi, K.R. Olson, “Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras”. Biochem Pharmacol. Vol. 85, no. 5, pp. 689-703, 2013. | ||
In article | View Article PubMed | ||
[136] | E.D. Kantor, J.W. Lampe, T.L. Vaughan, U. Peter s, C.D. Rehm, E. White, “Association between use of specialty dietary supplements and C-reactive protein concentrations”. Am J Epidemiol. Vol. 176, no.11, pp. 1002-13, 2012. | ||
In article | View Article PubMed | ||
[137] | R. Barr, K.Y. Chin, “Iatrogenic burns from garlic”. J Burn Care Res.Vol.34, no. 3, e214, 2013. | ||
In article | View Article PubMed | ||
[138] | Zhang, C,L., Zeng, T, Zhao, X.L., Yu, L.H., Zhu, Z.P., Xie, K.Q., 2012. “Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats”. Int J Biol Sci. Vol. 8, no. 3, 363-74. | ||
In article | View Article PubMed | ||
[139] | R. Nepravishta, R. Sabelli, E. Iorio, L. Micheli, M. Paci, S. Melino, “Oxidative species and S-glutathionyl conjugates in the apoptosis induction by allyl thiosulfate”. FEBS J. Vol. 279, pp. 154-67, 2012. | ||
In article | View Article PubMed | ||
[140] | B. Ray, N.B. Chauhan, D.K. Lahiri, “The aged garlic extract: (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD)”. Curr Med Chem. Vol.18, no. 22, pp. 3306-13, 2011. | ||
In article | View Article PubMed | ||
[141] | J.H. Jeong, H.R. Jeong, Y.N. Jo, H.J. Kim, J.H. Shin, H.J. Heo, “Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairment”. BMC Complement Altern Med.Vol.18, p. 268, 2013. | ||
In article | View Article PubMed | ||
[142] | L. Yan, I.H. Kim, “Effects of dietary supplementation of fermented garlic powder on growth performance, apparent total tract digestibility, blood characteristics and faecal microbial concentration in weanling pigs”. J Anim Physiol Anim Nutr (Berl). Vol. 97, no. 3, pp.457-64, 2013. | ||
In article | View Article PubMed | ||
[143] | J.S. Kang, T.M. Kim, T.J. Shim, E.I. Salim, B.S. Han, D.J. Kim, “Modifying effect of diallyl sulfide on colon carcinogenesis in C57BL/6J-ApcMin/⁺ mice”. Asian Pac J Cancer Prev. Vol. 13, no. 4, pp. 1115-8, 2012. | ||
In article | View Article PubMed | ||
[144] | M.L. McCullough, E.J. Jacobs, R. Shah, P.T. Campbell, S.M. Gapstur, “Garlic consumption and colorectal cancer risk in the CPS-II Nutrition Cohort”. Cancer Causes Control. Vol. 23, no. 10, pp. 1643-51, 2012. | ||
In article | View Article PubMed | ||
[145] | C.A. Gonzalez, L Lujan-Barroso, H.B. Bueno-de-Mesquita, M. Jenab, E.J. Duell, A. Agudo, A. Tjønneland, M.C. Boutron-Ruault, “Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up”. Int J Cancer. Vol. 131, no. 12, pp. 2910-9, 2012. | ||
In article | View Article PubMed | ||
[146] | S.V. Rana, l R Pa,, K. Vaiphei, S.K. Sharma, R.P. Ola, “Garlic in health and disease”. Nutr Res Rev. Vol. 24, no. 1, pp. 60-71, 2011. | ||
In article | View Article PubMed | ||
[147] | C. Cerella, M. Dicato, C. Jacob, M. Diederich, “Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 267-71, 2011. | ||
In article | View Article PubMed | ||
[148] | A. Tsubura, Y.C. Lai, M. Kuwata, N. Uehara, K. Yoshizawa, “Anticancer effects of garlic and garlic-derived compounds for breast cancer control”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 249-53, 2011. | ||
In article | View Article PubMed | ||
[149] | R.B. Walter, T.M. Brasky, F. Milano, E. White, “Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study”. Cancer Epidemiol Biomarkers Prev. Vol. 20, no. 10, pp. 2298-308, 2011. | ||
In article | View Article PubMed | ||
[150] | Brasky TM, Kristal AR, Navarro SL, Lampe JW, Peters U, Patterson RE, White E. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer. 2011; 63(4):573-82. | ||
In article | View Article PubMed | ||
[151] | S. Karmakar, S.R. Choudhury, N.L. Banik, S.K. Ray, “Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma”. Anticancer Agents Med Chem. Vol. 11, no. 4, pp.398-407, 2011. | ||
In article | View Article PubMed | ||
[152] | Bright-Gbebry M, Makambi KH, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LL. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study. BMC Complement Altern Med. 2011 11: 30. | ||
In article | View Article PubMed | ||
[153] | H.M. Alkreathy, Z.A. Damanhouri, N. Ahmed, M. Slevin, A.M. Osman, “Mechanisms of cardioprotective effect of aged garlic extract against Doxorubicin-induced cardiotoxicity”. Integr Cancer Ther. Vol. 11, no. 4, pp. 364-70, 2012. | ||
In article | View Article PubMed | ||
[154] | J.S. McLay, D. Stewar, t, J. George, C. Rore , S.D. Heys, “Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?” Eur J Clin Pharmacol. Vol. 68, no. 5, pp. 811-9, 2012. | ||
In article | View Article PubMed | ||
[155] | M. Miroddi, F. Calapai, G. Calapai, “Potential beneficial effects of garlic in oncohematology”. Mini Rev Med Chem. Vol. 11, no. 6, pp. 461-72, 2011. | ||
In article | View Article PubMed | ||
[156] | F.Y. Tang, E.P. Chiang, M.H. Pai, “Consumption of s-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model”. J Agric Food Chem. Vol. 58, no. 20, pp. 11156-64, 2010. | ||
In article | View Article PubMed | ||
[157] | D. Liang, Y. Qin, W. Zhao, X. Zhai, Z. Guo, R, Wang, L. Tong, L. Lin, H. Chen, YC. Wong, Z. Zhong, “S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions”. Cancer Lett. Vol. 310, no. 1, pp. 69-76, 2011. | ||
In article | View Article PubMed | ||
[158] | H. Javed, M.M. Khan, A. Khan, K. Vaibhav, A. Ahmad, G. Khuwaja, M.E. Ahmed, S.S. Raza, M. Ashafaq, R. Tabassum, M.S. Siddiqui, O.M. El-Agnaf, M.M. Safhi, F. Islam, “S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type”. Brain Res. 1389, pp. 133-42, 2011. | ||
In article | View Article PubMed | ||
[159] | Y. Iitsuka, Y. Tanaka, T. Hosono-Fukao, T. Hosono, T. Seki, T. Ariga, “Relationship between lipophilicity and inhibitory activity against cancer cell growth of nine kinds of alk(en)yl trisulfides with different side chains”. Oncol Res. Vol.18, no. 11-12, pp. 575-82, 2010. | ||
In article | PubMed | ||
[160] | T. Zeng, Y. Li, C.L. Zhang, L.H. Yu, Z.P. Zhu, X.L. Zhao, K.Q. Xie, “Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice”. J Food Sci. Vol. 78, no. 6, pp. 936-42, 2013. | ||
In article | View Article PubMed | ||
[161] | W Jiang, Y Huang, JP Wang, XY Yu, LY Zhang, The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo”. Asian Pac J Cancer Prev. Vol. 14, no. 8, pp. 4615-9. | ||
In article | View Article PubMed | ||
[162] | K. Berginc, A. Kristl, “The mechanisms responsible for garlic - drug interactions and their in vivo relevance”. Curr Drug Metab. Vol. 14, no. 1, pp. 90-101, 2013. | ||
In article | View Article PubMed | ||
[163] | H. Shirzad, F. Taji, M. Rafieian-Kopaei, “Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice”. J Med Food. Vol. 14, no. 9, pp. 969-74, 2011. | ||
In article | View Article PubMed | ||
[164] | L. Yi, Q. Su, “Molecular mechanisms for the anti-cancer effects of diallyl disulfide”. Food Chem Toxicol. Vol. 57, pp. 362-70, 2013. | ||
In article | View Article PubMed | ||
[165] | N. Druesne-Pecollo, P. Latino-Martel, “Modulation of histone acetylation by garlic sulfur compounds”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 254-9, 2011. | ||
In article | View Article PubMed | ||
[166] | E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich, D. Bagrel, “Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases”. Int J Oncol. Vol. 38, no. 4, pp. 1103-11, 2011. | ||
In article | PubMed | ||
[167] | V. Karagianni, E. Merikas, F. Georgopoulos, A. Gikas, N. Athanasopoulos, G. Malgarinos, G. Peros, J.K. Triantafillidis, “Risk factors for colorectal polyps: findings from a Greek case-control study”. Rev Med Chir Soc Med Nat Iasi. Vol.114, no. 3, pp. 662-70, 2013. | ||
In article | View Article | ||
[168] | B. Akgül, K.W. Lin, Ou, H.M. Yang, Y.H. Chen,, T.H. Lu, C.H. Chen, T. Kikuchi, Y.T. Chen, C.P. Tu, “Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: evidence for erythropoietin-independent erythropoiesis”. PLoS One. Vol. 5, no. 12, e15358, 2010. | ||
In article | View Article PubMed | ||
[169] | T. Chihara, K. Shimpo, T. Kaneko, H. Beppu, K. Mizutani, T. Higashiguchi, S. Sonoda, “Inhibition of 1, 2-dimethylhydrazine-induced mucin-depleted foci and O⁶-methylguanine DNA adducts in the rat colorectum by boiled garlic powder”. Asian Pac J Cancer Prev. Vol. 11, no. 5, pp. 1301-4, 2010. | ||
In article | |||
[170] | H. Hakimzadeh, T. Ghazanfari, B. Rahmati, H. Naderimanesh, “Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line”. Immunopharmacol Immunotoxicol. Vol. 32, no. 3, pp. 371-5, 2010. | ||
In article | View Article PubMed | ||
[171] | T. Ghazanfari, R. Yaraee, B. Rahmati, H. Hakimzadeh, J. Shams, M.R. Jalali-Nadoushan, “In vitro cytotoxic effect of garlic extract on malignant and nonmalignant cell lines”. Immunopharmacol Immunotoxicol. Vol. 33, no. 4, pp. 603-8, 2011. | ||
In article | View Article PubMed | ||
[172] | M.S. Butt, M.T. Sultan, M.S. Butt, J. Iqbal, “Garlic: nature's protection against physiological threats”. Crit Rev Food Sci Nutr. Vol. 49, no. 6, pp. 538-51, 2009. | ||
In article | View Article PubMed | ||
[173] | K. Lazarevic, A. Nagorni, N. Rancic, S. Milutinovic, L. Stosic, I. Ilijev, “Dietary factors and gastric cancer risk: hospital-based case control study”. J BUON. Vol. 15, no. 1, pp. 89-93, 2010. | ||
In article | PubMed | ||
[174] | S. Melino, R. Sabelli, M. Paci, “Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy”. Amino Acids. Vol. 41, no. 1, pp. 103-12, 2011. | ||
In article | View Article PubMed | ||
[175] | A. Piasek, A. Bartoszek, J. Namieśnik, “Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy”. Postepy Hig Med Dosw Vol. 63, pp. 142-58, 2009. | ||
In article | View Article | ||
[176] | N.P. Gullett , A.R. Ruhul Amin, S. Bayraktar, J.M. Pezzuto, D.M. Shin, F.R. Khuri, B.B .Aggarwal, Y.J. Surh, O. Kucuk, “Cancer prevention with natural compounds”. Semin Oncol. Vol. 37, no. 3, pp. 258-81. 2010. | ||
In article | View Article PubMed | ||
[177] | N. Ferrari, F. Tosetti, S. De Flora, F. Donatelli, I. Sogno, D.M. Noonan, A. Albini, “Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention”. Curr Drug Targets. Vol. 12, no. 13, pp. 1909-24, 2011. | ||
In article | View Article PubMed | ||
[178] | S. Kweon, K.A. Park, H. Choi, “Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis”. Life Sci Vol. 73, no. 19, pp. 2515-2526, 2003. | ||
In article | View Article | ||
[179] | M.C. Unnikrishnan, K.K. Soudamini, R. Kuttan, “Chemoprotection of garlic extract toward cyclophosphamide toxicity in mice”. Nutr Cancer Vol. 13, no.3, pp. 201-207, 1990. | ||
In article | View Article PubMed | ||
[180] | M.I. Thabrew, N.A. Samarawickrema, L.G. Chandrasena, “Protection by garlic against adriamycin induced alterations in the oxido-reductive status of mouse red blood cells”. Phytother Res Vol. 14, no. 3, pp. 215-217, 2000. | ||
In article | View Article | ||
[181] | S.P. Hussain, L.N. Jannu, A.R. Rao, “Chemopreventive action of garlic on methylcholanthrene-induced carcinogenesis in the uterine cervix of mice”. Cancer Lett. Vol. 49, no. 2, pp. 175-180, 1990. | ||
In article | View Article | ||
[182] | S. Balasenthil, K.S. Rao, S. Nagini, “Retinoic acid receptor-beta mRNA expression during chemoprevention of hamster cheek pouch carcinogenesis by garlic”. Asia Pac J Clin Nutr, Vol. 12, no. 2, pp. 215-218, 2003. | ||
In article | PubMed | ||
[183] | B.H. Wang, K.A. Zuzel, K. Rahman, “Protective effects of aged garlic extract against bromobenzene toxicity to precision cut rat liver slices”. Toxicology. Vol.126, no. 3, pp. 213-222, 1998. | ||
In article | View Article | ||
[184] | B.H. Wang, K.A. Zuzel, K. Rahman, “Treatment with aged garlic extract protects against bromobenzene toxicity to precision cut rat liver slices”. Toxicology. Vol. 132, no. 2-3, pp. 215-225, 1999. | ||
In article | View Article | ||
[185] | C. Dwivedi, S. Rohlfs, D. Jarvis, “Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide”. Pharm Res. Vol. 9, no. 12, pp. 1668-1670, 1992. | ||
In article | View Article PubMed | ||
[186] | V.L. Sparnins, G. Barany, L.W. Wattenberg, “Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse”. Carcinogenesis Vol. 9, no. 1, pp. 131-134, 1988. | ||
In article | View Article PubMed | ||
[187] | Belman, S., 1983. “Onion and garlic oils inhibit tumor promotion”. Carcinogenesis. Vol.4, no. 8, pp. 1063-1065, 1988. | ||
In article | View Article | ||
[188] | H. Nishino, A. Iwashima, Y. Itakura, “Antitumor-promoting activity of garlic extracts”. Oncology, Vol. 46 no. 4, pp. 277-280, 1989. | ||
In article | View Article PubMed | ||
[189] | M.J. Wargovich, “Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer”. Carcinogenesis Vol. 8, no. 3, pp. 487-489, 1987. | ||
In article | View Article PubMed | ||
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
[1] | M.C. Rocio, and J. L. Rion, “A Review of Some Antimicrobial Substances Isolated from Medicinal Plants Reported in the Literature Review of Phytochemical Analysis on Garlic 1978-1972”. Phytother. Vol. 3, pp. 117-125. 1982. | ||
In article | |||
[2] | J.A. Alli, B.E. Boboye, I.O. Okonko, A.F. Kolade, J.C. Nwanze, “In-Vitro assessments of the effects of garlic (Allium sativum) extract on clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus”. Advances in Applied Science Research Vol. 2, pp. 25-36, 2011. | ||
In article | View Article | ||
[3] | E. Block, “The chemistry of garlic and onions”. Sci Am. Vol.252, no. 3, pp. 114-119, 1985. | ||
In article | View Article PubMed | ||
[4] | Y.L. Chu, R. Raghu, KH Lu, C.T. Liu, S.H. Lin, YS Lai, WC Cheng, SH Lin, LY Sheen, “Autophagy Therapeutic Potential of Garlic in Human Cancer Therapy”. J Tradit Complement Med. Vol. 3, no. 3, pp. 159-162, 2013. | ||
In article | View Article PubMed | ||
[5] | T. Zeng, Y. Li, CL Zhang, LH Yu, ZP Zhu, XL Zhao, KQ Xie, “Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice”. J Food Sci. Vol. 78, no. 6, pp. 936-42, 2013. | ||
In article | View Article PubMed | ||
[6] | Z.Y. Jin, M Wu, R.Q. Han, X.F. Zhang, X.S. Wang, A.M. Liu, J.Y. Zhou, Q.Y. Lu, Z.F. Zhang, J.K. Zhao, “Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese population”. Cancer Prev Res (Phila), Vol. 6, no. 7, pp. 711-8, 2013. | ||
In article | View Article PubMed | ||
[7] | B. Zhu, L. Zou, L. Qi, R. Zhong, X. Miao, “Allium Vegetables and Garlic Supplements do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies”. Clin Gastroenterol Hepatol. pii: S1542-3565, no. 14, pp. 00451-0. | ||
In article | View Article | ||
[8] | C.A. González, N.Travier, L. Luján-Barroso, X. Castellsagué, F.X. Bosch, E. Roura, H.B. Bueno-de-Mesquita, D. Palli, “Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study”. Int J Cancer. Vol. 129, no. 2, pp. 449-59. 2011. | ||
In article | View Article PubMed | ||
[9] | B. Aggarwal, S. Prasad, B. Sung, S. Krishnan, S.Guha, “Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature”. Curr Colorectal Cancer Rep. Vol. 9, no. 1, pp. 37-56, 2013. | ||
In article | View Article PubMed | ||
[10] | G.Q. Yang, D. Wang, Y.S. Wang, Y. Y. Wang, K. Yang, “Radiosensitization effect of black garlic extract on lung cancer cell line Lewis cells”. Zhongguo Zhong Xi Yi Jie He Za Zhi. Vol. 33, no. 8, pp. 1093-7, 2013. | ||
In article | PubMed | ||
[11] | D.H. Alpers, “Garlic and its potential for prevention of colorectal cancer and other conditions”. Curr Opin Gastroenterol. Vol. 25, no. 2, pp. 116-21, 2009. | ||
In article | View Article PubMed | ||
[12] | M. Dong, G. Yang, H. Liu, X. Liu, S. Lin, D. Sun, Y. Wang, “Aged black garlic extract inhibits HT29 colon cancer cell growth via the PI3K/Akt signaling pathway”. Biomed Rep. Vol. 2, no. 2, pp. 250-254, 2014. | ||
In article | PubMed PubMed | ||
[13] | W. Zhang, H. Xiao, K.L. Parkin, “Apoptosis in MCF-7 breast cancer cells induced by S-alkenylmercaptocysteine (CySSR) species derived from Allium tissues in combination with sodium selenite”. Food Chem Toxicol.68C, pp. 1-10, 2014. | ||
In article | View Article PubMed | ||
[14] | G.C. Wallace, C.P. Haar, W.A. Vandergrift, P. Giglio, Y.N. Dixon-Mah, A.K. Varma, S.K. Ray, S.J. Patel, N.L. Banik, A. Das, “Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition”. J Neurooncol. Vol. 114, no. 1, pp. 43-50, 2013. | ||
In article | View Article PubMed | ||
[15] | Nohara T, Fujiwara Y, Ikeda T, Murakami K, Ono M, Nakano D, Kinjo J. Cyclic sulfoxides garlicnins B2, B3, B4, C2, and C3 from Allium sativum. Chem Pharm Bull (Tokyo). Vol. 61, no. 7, pp. 695-9. 2013. | ||
In article | View Article | ||
[16] | E. Appel, A.Rabinkov, M. Neeman, F. Kohen, D. Mirelman, “Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma”. J Drug Target.Vol.19, no. 5, pp. 326-35, 2011. | ||
In article | View Article PubMed | ||
[17] | S.S. Shord, K. Shah, A. Lukose, “Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals”. Integr Cancer Ther. Vol. 8, no. (3), pp. 208-27, 2009. | ||
In article | View Article | ||
[18] | C.H.Kaschula, R. Hunter, M.I. Parker, “Garlic-derived anticancer agents: structure and biological activity of ajoene”. Biofactors. Vol. 36, no. 1, pp. 78-85, 2010. | ||
In article | View Article | ||
[19] | Omar S. H. Al-Wabel N. A. Organosulfuric compounds and possible mechanism of garlic in cancer. 2010; 18(1); 51-58. | ||
In article | View Article | ||
[20] | S. Quintero-Fabián, D. Ortuño-Sahagún, M. Vázquez-Carrera, R.I. López-Roa, “Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes”. Mediators Inflamm. 381815, 2013. | ||
In article | PubMed PubMed | ||
[21] | M. Jo, H.M. Yun, K.R. Park, M.H. Park, D.H. Lee, S.H. Cho, H.S. Yoo, Y.M. Lee, H.S. Jeong, Y. Kim ,J.K. Jung,B.Y. Hwang,M.K. Lee, N.D. Kim, S.B. Han, J.T. Hong, “Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6”. PLoS One. Vol. 9, no. 3, e91508, 2014. | ||
In article | View Article PubMed | ||
[22] | J.O. Ban, H.S. Lee, H.S. Jeong, S. Song, B.Y. Hwang, D.C. Moon, Y. Yoon, do, S.B. Han, J.T. Hong, “Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}” B. Mol Cancer Res. Vol. 7, no.6, pp. 870-9, 2009. | ||
In article | View Article PubMed | ||
[23] | N.J. Shaheen, C. Hur, “Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus”. Gastroenterology. Vol. 145, no. 2, pp. 273-6, 2013. | ||
In article | View Article PubMed | ||
[24] | C. Busch, C. Jacob, A. Anwar, T. Burkholz, L. Aicha, Ba, C. Cerella, M. Diederich, W. Brandt, L. Wessjohann, M. Montenarh, “Diallylpolysulfides induce growth arrest and apoptosis”. Int J Oncol. Vol. 36, no.3, pp.743-9, M., 2010. | ||
In article | View Article | ||
[25] | E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, J. Yuan, “Human ICE/CED-3 protease nomenclature”. Vol. 87, no. 2, pp. 171, 1996. | ||
In article | View Article | ||
[26] | Entrez Gene: CASP3 caspase 3, apoptosis-related cysteine peptidase. | ||
In article | |||
[27] | S. Ghavami, M. Hashemi, S.R. Ande, B. Yeganeh, W. Xiao, M. Eshraghi, C.J. Bus, K. Kadkhoda, E. Wiechec, A.J. Halayko, M. Los, “Apoptosis and cancer: mutations within caspase genes”. J. Med. Genet. Vol. 46, no. 8, pp. 497-510, 2009. | ||
In article | View Article PubMed | ||
[28] | D.Y. Shin, H.J. Cha, G.Y. Kim, W.J. Kim, Y.H. Choi, “Inhibiting invasion into human bladder carcinoma 5637 cells with diallyl trisulfide by inhibiting matrix metalloproteinase activities and tightening tight junctions”. Int J Mol Sci. Vol. 14, no. 10, pp.19911-22, 2013. | ||
In article | View Article PubMed | ||
[29] | H. Vakifahmetoglu-Norberg, B. Zhivotovsky, “The unpredictable caspase-2: what can it do?” Trends Cell Biol. Vol. 20, pp.150-159, 2010 . | ||
In article | View Article PubMed | ||
[30] | H.B. Ma, S. Huang, X.R. Yin, Y. Zhang, Z.L. Di. “Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells”. World J Gastroenterol. Vol. 20, no. (1), pp. 193-203, 2014. | ||
In article | |||
[31] | N.N. Danial, S.J. Korsmeyer, “Cell death: critical control points” Cell. Vol. 116, pp. 205-219, 2004. | ||
In article | View Article | ||
[32] | J.F. Kerr, A.H. Wyllie, A.R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics”, Br. J. Cancer, Vol. 26, pp. 239-257, 1972. | ||
In article | View Article PubMed | ||
[33] | J.C. Reed, “Bcl-2 family proteins”, Oncogene Vol. 17, pp. 3225-3236, 1998. | ||
In article | View Article PubMed | ||
[34] | X. Lan, H. Sun, J. Liu, Y. Lin, Z. Zhu, X. Han, X. Sun, X. Li, H. Zhang, Z. Tang, “Effects of garlic oil on pancreatic cancer cells”. Asian Pac J Cancer Prev. Vol.14, no. 10, pp. 5905-10, 2013. | ||
In article | View Article PubMed | ||
[35] | Z. Xu, H. Wang, Y. Chen, G. Mao, Y. Hu, T. Zeng, K. Xie, “Preventive effects of garlic oil against the benzene-induced hematotoxicity in mice”. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. Vol. 32, no. 5, pp. 373-5, 2014. | ||
In article | PubMed | ||
[36] | H.K. Na, E.H. Kim, M.A. Choi, J.M. Park, D.H. Kim, Y.J. Surh, “Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1”. Biochem Pharmacol. Vol. 84, no. 10, pp. 1241-50, 2012. | ||
In article | View Article PubMed | ||
[37] | J.H. Cha, Y.J. Choi, S.H. Cha, C.H. Choi, W.H. Cho, “Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway”. Oncol Rep. Vol. 28, no. 1, pp. 41-8, 2012. | ||
In article | View Article | ||
[38] | Y.L. Chu, C.T. Ho, J.G. Chung, R. Rajasekaran, L.Y. Sheen, “Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells”. J Agric Food Chem. Vol. 60, no. 34, pp. 8363-71, 2012. | ||
In article | View Article PubMed | ||
[39] | Y.B. Wang, J. Qin, X.Y. Zheng, Y. Bai, K. Yang, L.P. Xie, “Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells”. Phytomedicine. Vol. 17, no. 5, pp. 363-8, 2010. | ||
In article | View Article PubMed | ||
[40] | W. Zhang, M. Ha, Y. Gong, Y. Xu, N. Dong, Y. Yuan, “Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways”. Oncol Rep. Vol. 24, no. 6, pp. 1585-92, 2010. | ||
In article | PubMed | ||
[41] | W. Bat-Chen, T. Golan, I. Peri, Z, Ludmer, B. Schwartz, “Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2.” Nutr Cancer. Vol. 62(7), pp. 947-57, 2010. | ||
In article | View Article PubMed | ||
[42] | M. Kelkel, C. Cerella, F. Mack, T. Schneider, C. Jacob, M. Schumacher, M. Dicato, M. Diederich, “ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis”. Carcinogenesis. Vol. 33, no. 11, pp. 2162-71, 2012. | ||
In article | View Article PubMed | ||
[43] | C.S.Yu, A.C. Huang, K.C. Lai, Y.P. Huang, M.W. Lin, J.S. Yang, J.G. Chung, “Diallyl trisulfide induces apoptosis in human primary colorectal cancer cells”. Oncol Rep. Vol. 28, no. 3, pp. 949-54, 2012. | ||
In article | PubMed | ||
[44] | Y. Lee, H. Kim, J. Lee, K. Kim, “Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell’. Biol Pharm Bull. Vol. 34, no. 5, pp. 677-81, 2011. | ||
In article | View Article PubMed | ||
[45] | M. Murai, T. Inoue, M. Suzuki-Karasaki, T. Ochiai, C. Ra , S. Nishida, Y. Suzuki-Karasaki, “Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis”. Int J Oncol. Vol. 41, no. 6, pp. 2029-37, 2012. | ||
In article | PubMed | ||
[46] | L. Li, T. Sun, J. Tian, K. Yang, K. Yi, P. Zhang, “Garlic in clinical practice: an evidence-based overview”. Crit Rev Food Sci Nutr. Vol. 53, no. 7, pp. 670-81, 2013. | ||
In article | View Article PubMed | ||
[47] | P. Dasgupta, S.S. Bandyopadhyay, “Role of di-allyl disulfide, a garlic component in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines”. Nutr Cancer. Vol. 65, no. 4, pp. 611-22, 2013. | ||
In article | View Article PubMed | ||
[48] | Malki A, El-Saadani M, Sultan AS. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol Ther. 2009; 8(22): 2175-85. | ||
In article | View Article PubMed | ||
[49] | Knowles, L.M., Milner, J.A., 2001. Possible mechanism by which allyl sulfides suppress neoplastic cell proliferation. J Nutr.; Vol. 131, no. 3s, 1061S-1066S. | ||
In article | PubMed | ||
[50] | H.J. Sun, L.Y. Meng, Y. Shen ,Y.Z. Zhu, H.R. Liu, “S-benzyl-cysteine-mediated cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells”. Asian Pac J Cancer Prev. Vol. 14, no.11, pp. 6379-84, 2013. | ||
In article | View Article PubMed | ||
[51] | T.A. Miller, J.Witter, David, S. Belvedere, “Histone Deacetylase Inhibitors”. Journal of Medicinal Chemistry, Vol. 46, no. 24, pp. 5097-116, 2003. | ||
In article | View Article PubMed | ||
[52] | Mwakwari, Sandra., V. Patil, W. Guerrant, A. Oyelere, “Macrocyclic Histone Deacetylase Inhibitors”. Current Topics in Medicinal Chemistry Vol. 10, no. (14), pp. 1423-40, 2010. | ||
In article | View Article | ||
[53] | V. Patil, Guerrant., William Chen., C. Po, B. Gryder, Benicewicz, B. Derek, Khan, I. Shabana, Tekwani, L. Babu, Oyelere, K. Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol.18, pp. 415-425, 2010. | ||
In article | View Article PubMed | ||
[54] | Druesne-Pecollo N, Latino-Martel P. Modulation of histone acetylation by garlic sulfur compounds. Anticancer Agents Med Chem. Vol.11, no. 3, pp. 254-9. 2011. | ||
In article | View Article PubMed | ||
[55] | A.C. Chueh, J.W. Tse, L. Tögel, J.M. Mariadason, “Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells”. Antioxidants & Redox Signaling, Vol. 23, no. 1, pp. 66-84. | ||
In article | View Article | ||
[56] | M.O. Altonsy, S.C. Andrews, “Diallyl disulphide, a beneficial component of garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29)”. Nutr Cancer, Vol. 63, no. (7), pp. 1104-13, 2011. | ||
In article | View Article | ||
[57] | B. Pagliei, K. Aquilano, S. Baldelli, M.R. Ciriolo, “Garlic-derived diallyl disulfide modulates peroxisome proliferator activated receptor gamma co-activator 1 alpha in neuroblastoma cells”. Biochem Pharmacol. Vol. 85, no. 3, pp. 335-44, 2013. | ||
In article | View Article PubMed | ||
[58] | Malumbres, Marcos; M. Barbacid, “Cell cycle, CDKs and cancer: a changing paradigm”. Nature Reviews Cancer, Vol. 9, PP. 153-166, 2009. | ||
In article | View Article | ||
[59] | Julian Lewis, 2007. “Molecular biology of the cell “(5th ed.). New York: Garland Science. | ||
In article | |||
[60] | K. Vermeulen, Van Bockstaele., R. Dirk, Berneman, N. Zwi, “The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer”. Cell Proliferation, Vol. 36, no. 3, pp. 131-149, 2003. | ||
In article | View Article PubMed | ||
[61] | Herman-Antosiewicz, et al, “Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1”. Pharm Res. Vol. 27, no. 6, pp. 1072-9, 2010. | ||
In article | View Article PubMed | ||
[62] | B. Czepukojc, A.K. Baltes, C. Cerella, M. Kelkel, U.M. Viswanathan, F. Salm, T. Burkholz, C.Schneider, M. Dicato, M. Montenarh, C. Jacob, M. Diederich, “Synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells”. Food Chem Toxicol. Vol. 64, pp. 249-57, 2014. | ||
In article | View Article PubMed | ||
[63] | A. Arunkumar, M.R. Vijayababu, N. Srinivasan, M.M. Aruldhas, J. Arunakaran, “Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3”. Mol Cell Biochem. Vol. 288, no. 1-2, pp. 107-113, 2006. | ||
In article | View Article PubMed | ||
[64] | P.P. Wu, H.W. Chung, K.C. Liu, R.S. Wu, J.S. Yang, N.Y. Tang, C. Lo, T.C. Hsia, C.C. Yu, F.S. Chueh, S.S. Lin, J.G. Chung, “Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways”. Int J Oncol. Vol. 38, no. 6, pp. 1605-13, 2011. | ||
In article | PubMed | ||
[65] | Y.L. Chu, C.T. Ho, J.G. Chung, R. Raghu, Y.C. Lo, L.Y. Sheen, “Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy”. J Agric Food Chem. Vol. 61, no. 41, pp. 9839-48, 2013. | ||
In article | View Article PubMed | ||
[66] | S. van den Heuvel, N.J. Dyson, “Conserved functions of the pRB and E2F families”. Nat. Rev. Mol. Cell Biol. Vol. 9, pp. 713-24, 2008. | ||
In article | View Article PubMed | ||
[67] | K.A. Cimprich, D. Cortez, “ATR: an essential regulator of genome integrity”. Nat. Rev. Mol. Cell Biol. Vol. 9, pp. 616-27, 2008. | ||
In article | View Article PubMed | ||
[68] | H.C. Reinhardt, M.B. Yaffe, “Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2”. Curr. Opin. Cell Biol. Vol. 21, pp. 245-55, 2009. | ||
In article | View Article PubMed | ||
[69] | Lindqvist, A., Rodrìguez-Bravo, V., Medema R.H., 2009. “The decision to enter mitosis: feedback and redundancy in the mitotic entry network”. J. Cell Biol. 185, vol.2, 193-202. | ||
In article | View Article | ||
[70] | V. Pei Patil, Guerrant., William Chen., C. Po, B. Gryder., Benicewicz, B. Derek, Khan, I. Shabana, L. Tekwani, Babu, Oyelere, K. Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol. 18, pp. 415-425, 2010. | ||
In article | View Article PubMed | ||
[71] | Kaschula CH, Hunter R, Stellenboom N, Caira MR, Winks S, Ogunleye T, Richards P, Cotton J, Zilbeyaz K, Wang Y, Siyo V, Ngarande E, Parker MI. Structure-activity studies on the anti-proliferation activity of ajoene analogues in WHCO1 oesophageal cancer cells. Eur J Med Chem.Vol.50, pp. 236-54, 2012 | ||
In article | View Article PubMed | ||
[72] | P. Pratheeshkumar, P. Thejass, G. Kutan, “Diallyl disulfide induces caspase-dependent apoptosis via mitochondria-mediated intrinsic pathway in B16F-10 melanoma cells by up-regulating p53, caspase-3 and down-regulating pro-inflammatory cytokines and nuclear factor-κβ-mediated Bcl-2 activation”. J Environ Pathol Toxicol Oncol. Vol. 29, pp. 113-25, 2010. | ||
In article | View Article PubMed | ||
[73] | Herman-Antosiewicz, “Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1”. Pharm Res. Vol. 27, pp. 1072-9, 2010. | ||
In article | View Article PubMed | ||
[74] | D.Y. Shin, G.Y. Kim, J.I. Kim, M.K. Yoon, T.K. Kwon, S.J. Lee, Y.W. Choi, H.S. Kang, Y.H. Yoo, Y.H. Choi, “Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells”. Toxicol In Vitro. Vol. 24, pp. 1569-76, 2010. | ||
In article | View Article PubMed | ||
[75] | Ji C, Ren F, Xu M. Caspase-8 and p38MAPK in DATS-induced apoptosis of human CNE2 cells. Braz J Med Biol Res. 2010; 43(9): 821-7. | ||
In article | View Article PubMed | ||
[76] | Shrotriya S, Kundu JK, Na HK, Surh YJ. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling. Cancer Res. 2010; 70(5): 1932-40. | ||
In article | View Article PubMed | ||
[77] | A. Musacchio, “Spindle assembly checkpoint: the third decade”. Philos. Trans. R. Soc. Lond., B, Biol. Sci. Vol. 366, no. 1584, pp. 3595-604, 2011 | ||
In article | View Article PubMed | ||
[78] | C.J. Lord, A. Ashworth, “The DNA damage response and cancer therapy”. Nature Vol. 481, no. 7381, pp.287-94, 2012. | ||
In article | View Article PubMed | ||
[79] | L. Wohlbold, R.P. Fisher “Behind the wheel and under the hood: functions of cyclin-dependent kinases in response to DNA damage”. DNA Repair (Amst.) Vol. 8, pp.1018-24, 2009. | ||
In article | View Article PubMed | ||
[80] | J.R. Skaar, M. Pagano, “Control of cell growth by the SCF and APC/C ubiquitin ligases”. Curr. Opin. Cell Biol. Vol. 21, pp. 816-24, 2009. | ||
In article | View Article PubMed | ||
[81] | S. Kim, H. Yu, “Mutual regulation between the spindle checkpoint and APC/C’. Semin. Cell Dev. Biol. Vol. 22, pp. 551-8, 2011. | ||
In article | View Article PubMed | ||
[82] | T. Devasagayam, J.C. Tilak, K.K. Boloor, Sane, S. Ketaki, S. Ghaskadbi Saroj, R.D. Lele, “Free Radicals and Antioxidants in Human Health: Current Status and Future Prospects”. Journal of Association of Physicians of India (JAPI) Vol. 52, pp. 796, 2004. | ||
In article | View Article | ||
[83] | M.E. Sosa Torres, J.P. Saucedo-Vázquez, P.M. Kroneck, Chapter 1, Section 3 The dark side of dioxygen”. In Kroneck PM, Torres ME. Sustaining Life on Planet Earth: Metalloenzymes Mastering Dioxygen and Other Chewy Gases. Metal Ions in Life Sciences 15. Springer. pp. 1-12, 2015. | ||
In article | |||
[84] | F. Muller, “The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging”. Journal of the American Aging Association Vol. 23, pp. 227-53, 2000. | ||
In article | View Article | ||
[85] | D. Han, E. Williams, E. Cadenas, “Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space”. The Biochemical Journal Vol. 353, pp. 411-6, 2001. | ||
In article | View Article PubMed | ||
[86] | Q. Kong, J.A. Beel, K.O. Lillehei, “A threshold concept for cancer therapy”. Medical Hypotheses Vol. 55, pp. 29-35, 2000. | ||
In article | View Article PubMed | ||
[87] | D. Trachootham, J. Alexandre, P. Huang, “Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?”. Nature Reviews. Drug Discovery. Vol.8, no. 7, pp. 579-91, 2009. | ||
In article | View Article PubMed | ||
[88] | N. Morihara, M. Hayama, H. Fujii, “Aged garlic extract scavenges superoxide radicals”. Plant Foods Hum Nutr. Vol. 66, pp. 17-21, 2011. | ||
In article | View Article PubMed | ||
[89] | K. Srinivasan, “Antioxidant potential of spices and their active constituents”. Crit Rev Food Sci Nutr. Vol. 54, no. 3, pp. 352-72, 2014. | ||
In article | View Article PubMed | ||
[90] | Capasso A. Antioxidant action and therapeutic efficacy of Allium sativum L. Molecules. Vol. 18, no. 1, pp. 690-700, 2013. | ||
In article | View Article PubMed | ||
[91] | K. Chandra-Kuntal, J. Lee, S.V. Singh, “Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic”. Breast Cancer Res Treat. Vol.138, pp. 69-79, 2013. | ||
In article | View Article PubMed | ||
[92] | Saidu NE, Abu Asali I, Czepukojc B, Seitz B, Jacob C, Montenarh M. Comparison between the effects of diallyl tetrasulfide on human retina pigment epithelial cells (ARPE-19) and HCT116 cells. Biochim Biophys Acta.; Vo. 1830, no. 11, pp. 5267-76. 2013. | ||
In article | View Article PubMed | ||
[93] | A. Djuv, O.G. Nilsen, A. Steinsbekk, “The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study”. BMC Complement Altern Med. Vol. 13, pp. 295, 2013. | ||
In article | View Article PubMed | ||
[94] | V.M. Dirsch, A.L. Gerbes, A.M. Vollmar, “Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB”. Mol Pharmacol. Vol. 53, no. 3, pp. 402-407, 1998. | ||
In article | PubMed | ||
[95] | Pinto JT, Rivlin RS. Antiproliferative effects of allium derivatives from garlic. J Nutr. Vol. 131, no. 3s, pp. 1058S-60S., 2001. | ||
In article | PubMed | ||
[96] | G.J. Blake, P.M. Ridker, K.M. Kuntz, “Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia”. Am J Med. Vol. 114, no.6, pp. 485-94, 2003. | ||
In article | View Article | ||
[97] | M. Ali, M. Thomson, M. Afzal, “Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance”. Prostaglandins Leukot Essent Fatty Acids. Vol.62, no. 2: pp. 55-73, 2000. | ||
In article | View Article PubMed | ||
[98] | E. Padilla-Camberos, G. Zaitseva, C. Padill, a, A.M. Puebla, “Antitumoral activity of allicin in murine lymphoma L5178Y”. Asian Pac J Cancer Prev. Vol. 11, no. 5, pp. 1241-4, 2010. | ||
In article | PubMed | ||
[99] | D. Xiao, J.T. Pinto, J.W. Soh, “Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation”. Cancer Res; Vol. 63, no. (20), pp. 6825-6837, 2003. | ||
In article | View Article | ||
[100] | R. Bradley, J. Endres, D. Hockenberry, “Investigation of garlic-induced apoptosis in breast cancer cell lines”. International Scientific Conference on Complementary, Alternative and Integrative Medicine Research, Boston, MA., 2002. | ||
In article | |||
[101] | Hu X, Cao BN, Hu G, et al. Attenuation of cell migration and induction of cell death by aged garlic extract in rat sarcoma cells. Int J Mol Med 2002; Vol. 9, 6, pp. 641-643. | ||
In article | View Article | ||
[102] | C.M. Tilli, A.J. Stavast-Kooy, J.D. Vuerstaek, “The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis”. Arch Dermatol Res, vol. 295, no. (3), pp. 117-123, 2003. | ||
In article | View Article | ||
[103] | M. Li, J.R. Ciu, Y. Ye, “Antitumor activity of Z-ajoene, a natural compound purified from garlic: antimitotic and microtubule-interaction properties”. Carcinogenesis. Vol. 23, no. 4, pp. 573-579, 2002. | ||
In article | View Article PubMed | ||
[104] | N. Morioka, L.L. Sze, D.L. Morton, “A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A”. Cancer Immunol Immunother; Vol. 37, no. 5, pp. 316-322, 1993. | ||
In article | View Article PubMed | ||
[105] | C.P. Siegers, B. Steffen, A. Robke, “The effects of garlic preparation against human tumour cell proliferation”. Phytomedicine Vol. 6, no. (1), pp.7-11, 1999. | ||
In article | View Article | ||
[106] | J.A. Milner, “Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlicand carcinogenesis”. Adv Exp Med Biol. Vol. 492, pp. 69-81, 2001. | ||
In article | View Article PubMed | ||
[107] | B.H. Lau, P.P. Tadi, J.M. Tosk, “Allium sativum (garlic) and cancer prevention”. Nutrit Res Vol. 10, pp. 937-948, 1990. | ||
In article | View Article | ||
[108] | M.J. Wargovich, N. Uda, C.Woods, “Allium vegetables: their role in the prevention of cancer”. B2iochem Soc Transl Vol. 24, no. 3, pp. 811-814, 1996. | ||
In article | View Article | ||
[109] | Z. Wang, Z. Liu, Z. Cao, L. Li, “Allicin induces apoptosis in EL-4 cells in vitro by activation of expression of caspase-3 and -12 and up-regulation of the ratio of Bax/Bcl-2”. Nat Prod Res. Vol. 26, no. 11, pp. 1033-7, 2012. | ||
In article | View Article PubMed | ||
[110] | Y.M. Nkrumah-Elie, J.S. Reuben , A.M. Hudson, E. Taka, R. Badisa, T. Ardley, B. Israel, S.Y. Sadrud-Din, E.T. Oriaku, S.F. Darling-Reed, “The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells”. Nutr Cancer. Vol. 64, no. 7, pp. 1112-21, 2012. | ||
In article | View Article PubMed | ||
[111] | A.K. Yang, S.M. He, L. Liu, J.P. Liu, M.Q. Wei, S.F. Zhou, “Herbal interactions with anticancer drugs: mechanistic and clinical considerations”. Curr Med Chem. Vol. 17, no. 16, pp. 1635-78, 2010. | ||
In article | View Article PubMed | ||
[112] | E.J. Kim, D.H. Lee, H.J. Kim, S.J. Lee, J.O. Ban, M.C. Cho, H.S. Jeong, Y. Yang, J.T. Hong, Y. Yoon, do, “Thiacremonone, a sulfur compound isolated from garlic, attenuates lipid accumulation partially mediated via AMPK activation in 3T3-L1 adipocytes”. J Nutr Biochem. Vol. 23, no. 12, pp. 1552-8, 2012. | ||
In article | View Article PubMed | ||
[113] | T. Kaneko, K. Shimpo, T. Chihara, H. Beppu, A. Tomatsu, M. Shinzato, T. Yanagida, T. S. Sonoda, A. Futamura, A. Ito, T.Higashiguchi, “Inhibition of ENNG-induced pyloric stomach and small intestinal carcinogenesis in mice by high temperature- and pressure-treated garlic”. Asian Pac J Cancer Prev. Vol. 13, no. 5, pp. 1983-8, 2012. | ||
In article | View Article PubMed | ||
[114] | S.D. Stan, S.V. Singh, “Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide inhuman prostate cancer cells”. Clin Cancer Res. Vol. 15, no. 15, pp. 4895-903, 2009. | ||
In article | View Article PubMed | ||
[115] | E.R. Hahm, S.V. Singh, “Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells”. Breast Cancer Res Treat. Vol. 144, no. 1, pp. 47-57, 2014. | ||
In article | View Article PubMed | ||
[116] | D.P. Lane, “Cancer. p53, guardian of the genome”, Nature, Vol. 358, pp. 15-16, 1992. | ||
In article | View Article PubMed | ||
[117] | H. Hu, X.P. Zhang, Y.L. Wang, C.W. Chua, S.U. Luk, Y.C. Wong, M.T. Ling, X.F. Wang, K.X. Xu, “Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells”. Mol Med Rep. Vol. 4, no. 1, pp. 9-16, 2011. | ||
In article | PubMed | ||
[118] | M.L. Antony, S.H. Kim, S.V. Singh, “Critical role of p53 upregulated modulator of apoptosis in benzyl isothiocyanate-induced apoptotic cell death”. PLoS One. Vol. 7, no. 2:e32267, 2012. | ||
In article | View Article PubMed | ||
[119] | M. Iciek, I. Kwiecień, G. Chwatko, M. Sokołowska-Jeżewicz, D. Kowalczyk-Pachel, H. Rokita, “The effects of garlic-derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells”. Cell Biochem Funct. Vol. 30, no. 3, pp. 198-204, 2012. | ||
In article | View Article PubMed | ||
[120] | Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu HF, Tang NY, Hsia TC, Ho HC, Chung JG. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions. Environ Toxicol. Vol. 28, no. 9: 479-88. | ||
In article | View Article PubMed | ||
[121] | H.S. Park, G.Y. Kim, I.W. Choi, N.D. Kim, H.J. Hwang, Y.W. Choi, Y.H. Choi, “Inhibition of matrix metalloproteinase activities and tightening of tight junctions by dially l disulfide in AGS human gastric carcinoma cells”. J Food Sci. Vol. 76, no. 4, pp. 105-11, 2011. | ||
In article | View Article PubMed | ||
[122] | Z. Liu, M. Li , K. Chen ,J. Yang , R. Chen ,T. Wang, J. Liu , W. Yang , Z. Ye. S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells. Mol Med Rep. Vol. 5, no. 2, pp. 439-43, 2012. | ||
In article | PubMed | ||
[123] | M.H. Pai, Y.H. Kuo, E.P. Chiang, F.Y. Tang, “S-Allylcysteine inhibits tumour progression and the epithelial-mesenchymal transition in a mouse xenograft model of oral cancer”. Br J Nutr. Vol. 108, no. 1, pp. 28-38, 2012 | ||
In article | View Article PubMed | ||
[124] | V. Pei Patil, Guerrant, William Chen., C. Po, B. Gryder., Benicewicz, B. Derek, Khan, I.Shabana, Tekwani, L.Babu, Oyelere, K.Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol.18, pp. 415-425, 2010. | ||
In article | View Article PubMed | ||
[125] | K.T. Ng, D.Y. Guo, Q. Cheng, W. Geng, C.C. Ling, C.X. Li, X.B. Liu, Y.Y. Ma, C.M. Lo, R.T. Poon, S.T. Fan, K. Man, “A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma”. PLoS One. Vol. 7, no. 2, e31655, 2012. | ||
In article | View Article PubMed | ||
[126] | D.F. Romagnolo, CD Davis, JA Milner, “Phytoalexins in cancer prevention”. Front Biosci (Landmark Ed). Vol. 17, pp. 2035-58, 2012. | ||
In article | View Article | ||
[127] | C.G. Yedjou, P.B. Tchounwou, “In vitro assessment of oxidative stress and apoptotic mechanisms of garlic extract in the treatment of acute promyelocytic leukemia”. J Cancer Sci Ther. (Suppl 3) 6, 2012. | ||
In article | |||
[128] | Y.M. Nkrumah-Elie, J.S. Reuben, A.M. Hudson, E. Taka, R. Badisa, T. Ardley, B. Israel, S.Y. Sadrud-Din, E.T. Oriaku, S.F. Darling-Reed, “The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells”. Nutr Cancer. Vol. 64, no. 7, pp. 1112-21, 2012. | ||
In article | View Article PubMed | ||
[129] | A. Borkowska, N. Knap, J. Antosiewicz, “Diallyl trisulfide is more cytotoxic to prostate cancer cells PC-3 than to noncancerous epithelial cell line PNT1A: a possible role of p66Shc signaling axis”. Nutr Cancer. Vol. 65, no. 5, pp. 711-7, 2013. | ||
In article | View Article PubMed | ||
[130] | Y.S. Huang, N. Xie, Q. Su, J. Su, C. Huang, Q.J. Liao, “Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes”. Mol Med Rep. Vol. 4, no. 3, pp. 553-9, 2011. | ||
In article | PubMed | ||
[131] | F.S. Yu, C.C. Wu, C.T. Chen, S.P. Huang, J.S. Yang, Y.M. Hsu, P.P. Wu, S.W. Ip, J.P. Lin, J.G. Lin, J.G. Chung, “Diallyl sulfide inhibits murine WEHI-3 leukemia cells in BALB/c mice in vitro and in vivo”. Hum Exp Toxicol. Vol. 12, pp. 785-90, 2009. | ||
In article | View Article PubMed | ||
[132] | M.L. Antony, S.V. Singh, “Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide”. Indian J Exp Biol. Vol. 49, no. 11, pp. 805-16. 2011. | ||
In article | PubMed PubMed | ||
[133] | C.Y. Chen, C.F. Huang, Y.T. Tseng, S.Y. Kuo, “Diallyl disulfide induces Ca2+ mobilization in human colon cancer cell line SW480”. Arch Toxicol. Vol. 86, no. 2, pp. 231-8, 2012. | ||
In article | View Article PubMed | ||
[134] | S. Modem, S.E. Dicarlo, T.R. Reddy, “Fresh Garlic Extract Induces Growth Arrest and Morphological Differentiation of MCF7 Breast Cancer Cells”. Genes Cancer.Vol. 3, no. 2, pp. 177-86, 2012. | ||
In article | View Article PubMed | ||
[135] | K. Kashfi, K.R. Olson, “Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras”. Biochem Pharmacol. Vol. 85, no. 5, pp. 689-703, 2013. | ||
In article | View Article PubMed | ||
[136] | E.D. Kantor, J.W. Lampe, T.L. Vaughan, U. Peter s, C.D. Rehm, E. White, “Association between use of specialty dietary supplements and C-reactive protein concentrations”. Am J Epidemiol. Vol. 176, no.11, pp. 1002-13, 2012. | ||
In article | View Article PubMed | ||
[137] | R. Barr, K.Y. Chin, “Iatrogenic burns from garlic”. J Burn Care Res.Vol.34, no. 3, e214, 2013. | ||
In article | View Article PubMed | ||
[138] | Zhang, C,L., Zeng, T, Zhao, X.L., Yu, L.H., Zhu, Z.P., Xie, K.Q., 2012. “Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats”. Int J Biol Sci. Vol. 8, no. 3, 363-74. | ||
In article | View Article PubMed | ||
[139] | R. Nepravishta, R. Sabelli, E. Iorio, L. Micheli, M. Paci, S. Melino, “Oxidative species and S-glutathionyl conjugates in the apoptosis induction by allyl thiosulfate”. FEBS J. Vol. 279, pp. 154-67, 2012. | ||
In article | View Article PubMed | ||
[140] | B. Ray, N.B. Chauhan, D.K. Lahiri, “The aged garlic extract: (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD)”. Curr Med Chem. Vol.18, no. 22, pp. 3306-13, 2011. | ||
In article | View Article PubMed | ||
[141] | J.H. Jeong, H.R. Jeong, Y.N. Jo, H.J. Kim, J.H. Shin, H.J. Heo, “Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairment”. BMC Complement Altern Med.Vol.18, p. 268, 2013. | ||
In article | View Article PubMed | ||
[142] | L. Yan, I.H. Kim, “Effects of dietary supplementation of fermented garlic powder on growth performance, apparent total tract digestibility, blood characteristics and faecal microbial concentration in weanling pigs”. J Anim Physiol Anim Nutr (Berl). Vol. 97, no. 3, pp.457-64, 2013. | ||
In article | View Article PubMed | ||
[143] | J.S. Kang, T.M. Kim, T.J. Shim, E.I. Salim, B.S. Han, D.J. Kim, “Modifying effect of diallyl sulfide on colon carcinogenesis in C57BL/6J-ApcMin/⁺ mice”. Asian Pac J Cancer Prev. Vol. 13, no. 4, pp. 1115-8, 2012. | ||
In article | View Article PubMed | ||
[144] | M.L. McCullough, E.J. Jacobs, R. Shah, P.T. Campbell, S.M. Gapstur, “Garlic consumption and colorectal cancer risk in the CPS-II Nutrition Cohort”. Cancer Causes Control. Vol. 23, no. 10, pp. 1643-51, 2012. | ||
In article | View Article PubMed | ||
[145] | C.A. Gonzalez, L Lujan-Barroso, H.B. Bueno-de-Mesquita, M. Jenab, E.J. Duell, A. Agudo, A. Tjønneland, M.C. Boutron-Ruault, “Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up”. Int J Cancer. Vol. 131, no. 12, pp. 2910-9, 2012. | ||
In article | View Article PubMed | ||
[146] | S.V. Rana, l R Pa,, K. Vaiphei, S.K. Sharma, R.P. Ola, “Garlic in health and disease”. Nutr Res Rev. Vol. 24, no. 1, pp. 60-71, 2011. | ||
In article | View Article PubMed | ||
[147] | C. Cerella, M. Dicato, C. Jacob, M. Diederich, “Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 267-71, 2011. | ||
In article | View Article PubMed | ||
[148] | A. Tsubura, Y.C. Lai, M. Kuwata, N. Uehara, K. Yoshizawa, “Anticancer effects of garlic and garlic-derived compounds for breast cancer control”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 249-53, 2011. | ||
In article | View Article PubMed | ||
[149] | R.B. Walter, T.M. Brasky, F. Milano, E. White, “Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study”. Cancer Epidemiol Biomarkers Prev. Vol. 20, no. 10, pp. 2298-308, 2011. | ||
In article | View Article PubMed | ||
[150] | Brasky TM, Kristal AR, Navarro SL, Lampe JW, Peters U, Patterson RE, White E. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer. 2011; 63(4):573-82. | ||
In article | View Article PubMed | ||
[151] | S. Karmakar, S.R. Choudhury, N.L. Banik, S.K. Ray, “Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma”. Anticancer Agents Med Chem. Vol. 11, no. 4, pp.398-407, 2011. | ||
In article | View Article PubMed | ||
[152] | Bright-Gbebry M, Makambi KH, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LL. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study. BMC Complement Altern Med. 2011 11: 30. | ||
In article | View Article PubMed | ||
[153] | H.M. Alkreathy, Z.A. Damanhouri, N. Ahmed, M. Slevin, A.M. Osman, “Mechanisms of cardioprotective effect of aged garlic extract against Doxorubicin-induced cardiotoxicity”. Integr Cancer Ther. Vol. 11, no. 4, pp. 364-70, 2012. | ||
In article | View Article PubMed | ||
[154] | J.S. McLay, D. Stewar, t, J. George, C. Rore , S.D. Heys, “Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?” Eur J Clin Pharmacol. Vol. 68, no. 5, pp. 811-9, 2012. | ||
In article | View Article PubMed | ||
[155] | M. Miroddi, F. Calapai, G. Calapai, “Potential beneficial effects of garlic in oncohematology”. Mini Rev Med Chem. Vol. 11, no. 6, pp. 461-72, 2011. | ||
In article | View Article PubMed | ||
[156] | F.Y. Tang, E.P. Chiang, M.H. Pai, “Consumption of s-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model”. J Agric Food Chem. Vol. 58, no. 20, pp. 11156-64, 2010. | ||
In article | View Article PubMed | ||
[157] | D. Liang, Y. Qin, W. Zhao, X. Zhai, Z. Guo, R, Wang, L. Tong, L. Lin, H. Chen, YC. Wong, Z. Zhong, “S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions”. Cancer Lett. Vol. 310, no. 1, pp. 69-76, 2011. | ||
In article | View Article PubMed | ||
[158] | H. Javed, M.M. Khan, A. Khan, K. Vaibhav, A. Ahmad, G. Khuwaja, M.E. Ahmed, S.S. Raza, M. Ashafaq, R. Tabassum, M.S. Siddiqui, O.M. El-Agnaf, M.M. Safhi, F. Islam, “S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type”. Brain Res. 1389, pp. 133-42, 2011. | ||
In article | View Article PubMed | ||
[159] | Y. Iitsuka, Y. Tanaka, T. Hosono-Fukao, T. Hosono, T. Seki, T. Ariga, “Relationship between lipophilicity and inhibitory activity against cancer cell growth of nine kinds of alk(en)yl trisulfides with different side chains”. Oncol Res. Vol.18, no. 11-12, pp. 575-82, 2010. | ||
In article | PubMed | ||
[160] | T. Zeng, Y. Li, C.L. Zhang, L.H. Yu, Z.P. Zhu, X.L. Zhao, K.Q. Xie, “Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice”. J Food Sci. Vol. 78, no. 6, pp. 936-42, 2013. | ||
In article | View Article PubMed | ||
[161] | W Jiang, Y Huang, JP Wang, XY Yu, LY Zhang, The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo”. Asian Pac J Cancer Prev. Vol. 14, no. 8, pp. 4615-9. | ||
In article | View Article PubMed | ||
[162] | K. Berginc, A. Kristl, “The mechanisms responsible for garlic - drug interactions and their in vivo relevance”. Curr Drug Metab. Vol. 14, no. 1, pp. 90-101, 2013. | ||
In article | View Article PubMed | ||
[163] | H. Shirzad, F. Taji, M. Rafieian-Kopaei, “Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice”. J Med Food. Vol. 14, no. 9, pp. 969-74, 2011. | ||
In article | View Article PubMed | ||
[164] | L. Yi, Q. Su, “Molecular mechanisms for the anti-cancer effects of diallyl disulfide”. Food Chem Toxicol. Vol. 57, pp. 362-70, 2013. | ||
In article | View Article PubMed | ||
[165] | N. Druesne-Pecollo, P. Latino-Martel, “Modulation of histone acetylation by garlic sulfur compounds”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 254-9, 2011. | ||
In article | View Article PubMed | ||
[166] | E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich, D. Bagrel, “Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases”. Int J Oncol. Vol. 38, no. 4, pp. 1103-11, 2011. | ||
In article | PubMed | ||
[167] | V. Karagianni, E. Merikas, F. Georgopoulos, A. Gikas, N. Athanasopoulos, G. Malgarinos, G. Peros, J.K. Triantafillidis, “Risk factors for colorectal polyps: findings from a Greek case-control study”. Rev Med Chir Soc Med Nat Iasi. Vol.114, no. 3, pp. 662-70, 2013. | ||
In article | View Article | ||
[168] | B. Akgül, K.W. Lin, Ou, H.M. Yang, Y.H. Chen,, T.H. Lu, C.H. Chen, T. Kikuchi, Y.T. Chen, C.P. Tu, “Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: evidence for erythropoietin-independent erythropoiesis”. PLoS One. Vol. 5, no. 12, e15358, 2010. | ||
In article | View Article PubMed | ||
[169] | T. Chihara, K. Shimpo, T. Kaneko, H. Beppu, K. Mizutani, T. Higashiguchi, S. Sonoda, “Inhibition of 1, 2-dimethylhydrazine-induced mucin-depleted foci and O⁶-methylguanine DNA adducts in the rat colorectum by boiled garlic powder”. Asian Pac J Cancer Prev. Vol. 11, no. 5, pp. 1301-4, 2010. | ||
In article | |||
[170] | H. Hakimzadeh, T. Ghazanfari, B. Rahmati, H. Naderimanesh, “Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line”. Immunopharmacol Immunotoxicol. Vol. 32, no. 3, pp. 371-5, 2010. | ||
In article | View Article PubMed | ||
[171] | T. Ghazanfari, R. Yaraee, B. Rahmati, H. Hakimzadeh, J. Shams, M.R. Jalali-Nadoushan, “In vitro cytotoxic effect of garlic extract on malignant and nonmalignant cell lines”. Immunopharmacol Immunotoxicol. Vol. 33, no. 4, pp. 603-8, 2011. | ||
In article | View Article PubMed | ||
[172] | M.S. Butt, M.T. Sultan, M.S. Butt, J. Iqbal, “Garlic: nature's protection against physiological threats”. Crit Rev Food Sci Nutr. Vol. 49, no. 6, pp. 538-51, 2009. | ||
In article | View Article PubMed | ||
[173] | K. Lazarevic, A. Nagorni, N. Rancic, S. Milutinovic, L. Stosic, I. Ilijev, “Dietary factors and gastric cancer risk: hospital-based case control study”. J BUON. Vol. 15, no. 1, pp. 89-93, 2010. | ||
In article | PubMed | ||
[174] | S. Melino, R. Sabelli, M. Paci, “Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy”. Amino Acids. Vol. 41, no. 1, pp. 103-12, 2011. | ||
In article | View Article PubMed | ||
[175] | A. Piasek, A. Bartoszek, J. Namieśnik, “Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy”. Postepy Hig Med Dosw Vol. 63, pp. 142-58, 2009. | ||
In article | View Article | ||
[176] | N.P. Gullett , A.R. Ruhul Amin, S. Bayraktar, J.M. Pezzuto, D.M. Shin, F.R. Khuri, B.B .Aggarwal, Y.J. Surh, O. Kucuk, “Cancer prevention with natural compounds”. Semin Oncol. Vol. 37, no. 3, pp. 258-81. 2010. | ||
In article | View Article PubMed | ||
[177] | N. Ferrari, F. Tosetti, S. De Flora, F. Donatelli, I. Sogno, D.M. Noonan, A. Albini, “Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention”. Curr Drug Targets. Vol. 12, no. 13, pp. 1909-24, 2011. | ||
In article | View Article PubMed | ||
[178] | S. Kweon, K.A. Park, H. Choi, “Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis”. Life Sci Vol. 73, no. 19, pp. 2515-2526, 2003. | ||
In article | View Article | ||
[179] | M.C. Unnikrishnan, K.K. Soudamini, R. Kuttan, “Chemoprotection of garlic extract toward cyclophosphamide toxicity in mice”. Nutr Cancer Vol. 13, no.3, pp. 201-207, 1990. | ||
In article | View Article PubMed | ||
[180] | M.I. Thabrew, N.A. Samarawickrema, L.G. Chandrasena, “Protection by garlic against adriamycin induced alterations in the oxido-reductive status of mouse red blood cells”. Phytother Res Vol. 14, no. 3, pp. 215-217, 2000. | ||
In article | View Article | ||
[181] | S.P. Hussain, L.N. Jannu, A.R. Rao, “Chemopreventive action of garlic on methylcholanthrene-induced carcinogenesis in the uterine cervix of mice”. Cancer Lett. Vol. 49, no. 2, pp. 175-180, 1990. | ||
In article | View Article | ||
[182] | S. Balasenthil, K.S. Rao, S. Nagini, “Retinoic acid receptor-beta mRNA expression during chemoprevention of hamster cheek pouch carcinogenesis by garlic”. Asia Pac J Clin Nutr, Vol. 12, no. 2, pp. 215-218, 2003. | ||
In article | PubMed | ||
[183] | B.H. Wang, K.A. Zuzel, K. Rahman, “Protective effects of aged garlic extract against bromobenzene toxicity to precision cut rat liver slices”. Toxicology. Vol.126, no. 3, pp. 213-222, 1998. | ||
In article | View Article | ||
[184] | B.H. Wang, K.A. Zuzel, K. Rahman, “Treatment with aged garlic extract protects against bromobenzene toxicity to precision cut rat liver slices”. Toxicology. Vol. 132, no. 2-3, pp. 215-225, 1999. | ||
In article | View Article | ||
[185] | C. Dwivedi, S. Rohlfs, D. Jarvis, “Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide”. Pharm Res. Vol. 9, no. 12, pp. 1668-1670, 1992. | ||
In article | View Article PubMed | ||
[186] | V.L. Sparnins, G. Barany, L.W. Wattenberg, “Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse”. Carcinogenesis Vol. 9, no. 1, pp. 131-134, 1988. | ||
In article | View Article PubMed | ||
[187] | Belman, S., 1983. “Onion and garlic oils inhibit tumor promotion”. Carcinogenesis. Vol.4, no. 8, pp. 1063-1065, 1988. | ||
In article | View Article | ||
[188] | H. Nishino, A. Iwashima, Y. Itakura, “Antitumor-promoting activity of garlic extracts”. Oncology, Vol. 46 no. 4, pp. 277-280, 1989. | ||
In article | View Article PubMed | ||
[189] | M.J. Wargovich, “Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer”. Carcinogenesis Vol. 8, no. 3, pp. 487-489, 1987. | ||
In article | View Article PubMed | ||